CN113194908A - Set for caring skin - Google Patents
Set for caring skin Download PDFInfo
- Publication number
- CN113194908A CN113194908A CN201880100560.0A CN201880100560A CN113194908A CN 113194908 A CN113194908 A CN 113194908A CN 201880100560 A CN201880100560 A CN 201880100560A CN 113194908 A CN113194908 A CN 113194908A
- Authority
- CN
- China
- Prior art keywords
- water
- composition
- soluble
- kit according
- acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 claims abstract description 195
- 229920000642 polymer Polymers 0.000 claims abstract description 63
- 150000003839 salts Chemical class 0.000 claims abstract description 60
- 239000003349 gelling agent Substances 0.000 claims abstract description 56
- 229910021645 metal ion Inorganic materials 0.000 claims abstract description 47
- 239000000463 material Substances 0.000 claims abstract description 42
- 229910052751 metal Inorganic materials 0.000 claims abstract description 41
- 239000002184 metal Substances 0.000 claims abstract description 41
- 108010076876 Keratins Proteins 0.000 claims abstract description 17
- 102000011782 Keratins Human genes 0.000 claims abstract description 17
- 239000008346 aqueous phase Substances 0.000 claims abstract description 16
- 230000015572 biosynthetic process Effects 0.000 claims abstract description 10
- 201000009859 Osteochondrosis Diseases 0.000 claims abstract description 7
- 206010060932 Postoperative adhesion Diseases 0.000 claims abstract description 7
- 206010072170 Skin wound Diseases 0.000 claims abstract description 7
- 238000011049 filling Methods 0.000 claims abstract description 7
- -1 alkali metal salts Chemical class 0.000 claims description 69
- 229920000615 alginic acid Polymers 0.000 claims description 62
- 235000010443 alginic acid Nutrition 0.000 claims description 59
- 239000000835 fiber Substances 0.000 claims description 57
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 55
- 239000000758 substrate Substances 0.000 claims description 53
- 229910052783 alkali metal Inorganic materials 0.000 claims description 39
- 239000002738 chelating agent Substances 0.000 claims description 29
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 28
- 239000000499 gel Substances 0.000 claims description 27
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 claims description 26
- 239000002253 acid Substances 0.000 claims description 25
- 238000000034 method Methods 0.000 claims description 25
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 claims description 21
- 229940072056 alginate Drugs 0.000 claims description 20
- 239000000783 alginic acid Substances 0.000 claims description 20
- 229960001126 alginic acid Drugs 0.000 claims description 20
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 claims description 20
- 150000001340 alkali metals Chemical class 0.000 claims description 18
- 239000004354 Hydroxyethyl cellulose Substances 0.000 claims description 17
- 150000004781 alginic acids Chemical class 0.000 claims description 16
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 claims description 16
- 229920001277 pectin Polymers 0.000 claims description 15
- 235000010987 pectin Nutrition 0.000 claims description 15
- 239000001814 pectin Substances 0.000 claims description 15
- 239000011734 sodium Substances 0.000 claims description 15
- 229920001817 Agar Polymers 0.000 claims description 14
- 235000010419 agar Nutrition 0.000 claims description 13
- 239000008272 agar Substances 0.000 claims description 13
- 229910052708 sodium Inorganic materials 0.000 claims description 13
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 claims description 12
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 claims description 12
- 229920001525 carrageenan Polymers 0.000 claims description 12
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 claims description 12
- 229910052700 potassium Inorganic materials 0.000 claims description 12
- 235000010413 sodium alginate Nutrition 0.000 claims description 12
- 239000000661 sodium alginate Substances 0.000 claims description 12
- 229940005550 sodium alginate Drugs 0.000 claims description 12
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 11
- 239000013543 active substance Substances 0.000 claims description 11
- 239000004744 fabric Substances 0.000 claims description 11
- 239000001863 hydroxypropyl cellulose Substances 0.000 claims description 11
- 239000004745 nonwoven fabric Substances 0.000 claims description 11
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 claims description 10
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 10
- 239000011591 potassium Substances 0.000 claims description 10
- 229920000742 Cotton Polymers 0.000 claims description 9
- 229920002148 Gellan gum Polymers 0.000 claims description 9
- 239000001509 sodium citrate Substances 0.000 claims description 9
- 235000010410 calcium alginate Nutrition 0.000 claims description 8
- 229960002681 calcium alginate Drugs 0.000 claims description 8
- 235000010418 carrageenan Nutrition 0.000 claims description 8
- 239000000679 carrageenan Substances 0.000 claims description 8
- 229940113118 carrageenan Drugs 0.000 claims description 8
- 229910052744 lithium Inorganic materials 0.000 claims description 8
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical class [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 7
- 239000011575 calcium Substances 0.000 claims description 7
- 229910052791 calcium Inorganic materials 0.000 claims description 7
- 159000000007 calcium salts Chemical class 0.000 claims description 7
- 150000002148 esters Chemical class 0.000 claims description 7
- 235000010492 gellan gum Nutrition 0.000 claims description 7
- 239000000216 gellan gum Substances 0.000 claims description 7
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 claims description 6
- 229920000297 Rayon Polymers 0.000 claims description 6
- LCWAOCHOPBSGMU-UHFFFAOYSA-J aluminum;magnesium;sodium;hydrogen carbonate;oxygen(2-);silicon;trihydroxide Chemical compound [OH-].[OH-].[OH-].[O-2].[Na+].[Mg+2].[Al+3].[Si].OC([O-])=O LCWAOCHOPBSGMU-UHFFFAOYSA-J 0.000 claims description 6
- 150000001732 carboxylic acid derivatives Chemical class 0.000 claims description 6
- 150000001768 cations Chemical class 0.000 claims description 6
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims description 6
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 claims description 6
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 claims description 6
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 claims description 6
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 claims description 6
- 229920001223 polyethylene glycol Polymers 0.000 claims description 6
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 claims description 6
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 claims description 6
- 229920000433 Lyocell Polymers 0.000 claims description 5
- 239000002202 Polyethylene glycol Substances 0.000 claims description 5
- 239000000648 calcium alginate Substances 0.000 claims description 5
- 229910000019 calcium carbonate Inorganic materials 0.000 claims description 5
- OKHHGHGGPDJQHR-YMOPUZKJSA-L calcium;(2s,3s,4s,5s,6r)-6-[(2r,3s,4r,5s,6r)-2-carboxy-6-[(2r,3s,4r,5s,6r)-2-carboxylato-4,5,6-trihydroxyoxan-3-yl]oxy-4,5-dihydroxyoxan-3-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylate Chemical compound [Ca+2].O[C@@H]1[C@H](O)[C@H](O)O[C@@H](C([O-])=O)[C@H]1O[C@H]1[C@@H](O)[C@@H](O)[C@H](O[C@H]2[C@H]([C@@H](O)[C@H](O)[C@H](O2)C([O-])=O)O)[C@H](C(O)=O)O1 OKHHGHGGPDJQHR-YMOPUZKJSA-L 0.000 claims description 5
- 238000013329 compounding Methods 0.000 claims description 5
- 229920013819 hydroxyethyl ethylcellulose Polymers 0.000 claims description 5
- 235000010408 potassium alginate Nutrition 0.000 claims description 5
- 239000000737 potassium alginate Substances 0.000 claims description 5
- MZYRDLHIWXQJCQ-YZOKENDUSA-L potassium alginate Chemical compound [K+].[K+].O1[C@@H](C([O-])=O)[C@@H](OC)[C@H](O)[C@H](O)[C@@H]1O[C@@H]1[C@@H](C([O-])=O)O[C@@H](O)[C@@H](O)[C@H]1O MZYRDLHIWXQJCQ-YZOKENDUSA-L 0.000 claims description 5
- VKZRWSNIWNFCIQ-WDSKDSINSA-N (2s)-2-[2-[[(1s)-1,2-dicarboxyethyl]amino]ethylamino]butanedioic acid Chemical compound OC(=O)C[C@@H](C(O)=O)NCCN[C@H](C(O)=O)CC(O)=O VKZRWSNIWNFCIQ-WDSKDSINSA-N 0.000 claims description 4
- RPZANUYHRMRTTE-UHFFFAOYSA-N 2,3,4-trimethoxy-6-(methoxymethyl)-5-[3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxyoxane;1-[[3,4,5-tris(2-hydroxybutoxy)-6-[4,5,6-tris(2-hydroxybutoxy)-2-(2-hydroxybutoxymethyl)oxan-3-yl]oxyoxan-2-yl]methoxy]butan-2-ol Chemical compound COC1C(OC)C(OC)C(COC)OC1OC1C(OC)C(OC)C(OC)OC1COC.CCC(O)COC1C(OCC(O)CC)C(OCC(O)CC)C(COCC(O)CC)OC1OC1C(OCC(O)CC)C(OCC(O)CC)C(OCC(O)CC)OC1COCC(O)CC RPZANUYHRMRTTE-UHFFFAOYSA-N 0.000 claims description 4
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical class [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims description 4
- 229920001479 Hydroxyethyl methyl cellulose Polymers 0.000 claims description 4
- IMQLKJBTEOYOSI-GPIVLXJGSA-N Inositol-hexakisphosphate Chemical compound OP(O)(=O)O[C@H]1[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H]1OP(O)(O)=O IMQLKJBTEOYOSI-GPIVLXJGSA-N 0.000 claims description 4
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 claims description 4
- 239000010949 copper Chemical class 0.000 claims description 4
- 229910052802 copper Inorganic materials 0.000 claims description 4
- 150000007524 organic acids Chemical class 0.000 claims description 4
- 235000002949 phytic acid Nutrition 0.000 claims description 4
- 108010010803 Gelatin Proteins 0.000 claims description 3
- FENRSEGZMITUEF-ATTCVCFYSA-E [Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].OP(=O)([O-])O[C@@H]1[C@@H](OP(=O)([O-])[O-])[C@H](OP(=O)(O)[O-])[C@H](OP(=O)([O-])[O-])[C@H](OP(=O)(O)[O-])[C@H]1OP(=O)([O-])[O-] Chemical compound [Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].OP(=O)([O-])O[C@@H]1[C@@H](OP(=O)([O-])[O-])[C@H](OP(=O)(O)[O-])[C@H](OP(=O)([O-])[O-])[C@H](OP(=O)(O)[O-])[C@H]1OP(=O)([O-])[O-] FENRSEGZMITUEF-ATTCVCFYSA-E 0.000 claims description 3
- 239000008273 gelatin Substances 0.000 claims description 3
- 229920000159 gelatin Polymers 0.000 claims description 3
- 235000019322 gelatine Nutrition 0.000 claims description 3
- 235000011852 gelatine desserts Nutrition 0.000 claims description 3
- 239000004627 regenerated cellulose Substances 0.000 claims description 3
- 229940083982 sodium phytate Drugs 0.000 claims description 3
- UZVUJVFQFNHRSY-OUTKXMMCSA-J tetrasodium;(2s)-2-[bis(carboxylatomethyl)amino]pentanedioate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]C(=O)CC[C@@H](C([O-])=O)N(CC([O-])=O)CC([O-])=O UZVUJVFQFNHRSY-OUTKXMMCSA-J 0.000 claims description 3
- KXDHJXZQYSOELW-UHFFFAOYSA-N Carbamic acid Chemical compound NC(O)=O KXDHJXZQYSOELW-UHFFFAOYSA-N 0.000 claims description 2
- DRAJWRKLRBNJRQ-UHFFFAOYSA-N Hydroxycarbamic acid Chemical compound ONC(O)=O DRAJWRKLRBNJRQ-UHFFFAOYSA-N 0.000 claims description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 claims description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical class [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 2
- 229910052698 phosphorus Inorganic materials 0.000 claims description 2
- 239000011574 phosphorus Substances 0.000 claims description 2
- 229910052712 strontium Inorganic materials 0.000 claims description 2
- CIOAGBVUUVVLOB-UHFFFAOYSA-N strontium atom Chemical class [Sr] CIOAGBVUUVVLOB-UHFFFAOYSA-N 0.000 claims description 2
- SOBHUZYZLFQYFK-UHFFFAOYSA-K trisodium;hydroxy-[[phosphonatomethyl(phosphonomethyl)amino]methyl]phosphinate Chemical compound [Na+].[Na+].[Na+].OP(O)(=O)CN(CP(O)([O-])=O)CP([O-])([O-])=O SOBHUZYZLFQYFK-UHFFFAOYSA-K 0.000 claims description 2
- 239000011701 zinc Chemical class 0.000 claims description 2
- 229910052725 zinc Inorganic materials 0.000 claims description 2
- 239000003109 Disodium ethylene diamine tetraacetate Substances 0.000 claims 1
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 claims 1
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical class [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 claims 1
- 235000019301 disodium ethylene diamine tetraacetate Nutrition 0.000 claims 1
- 239000011572 manganese Chemical class 0.000 claims 1
- 229910052748 manganese Inorganic materials 0.000 claims 1
- 239000003352 sequestering agent Substances 0.000 abstract description 3
- 230000021148 sequestering of metal ion Effects 0.000 abstract description 3
- 229920001282 polysaccharide Polymers 0.000 description 42
- 239000005017 polysaccharide Substances 0.000 description 42
- 229920002678 cellulose Polymers 0.000 description 38
- 150000004804 polysaccharides Chemical class 0.000 description 37
- 210000003491 skin Anatomy 0.000 description 34
- 235000010980 cellulose Nutrition 0.000 description 30
- 229920002674 hyaluronan Polymers 0.000 description 30
- 229960003160 hyaluronic acid Drugs 0.000 description 30
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 29
- 239000001913 cellulose Substances 0.000 description 28
- 239000000047 product Substances 0.000 description 25
- 244000303965 Cyamopsis psoralioides Species 0.000 description 21
- 125000002091 cationic group Chemical group 0.000 description 19
- 239000003795 chemical substances by application Substances 0.000 description 19
- 230000000052 comparative effect Effects 0.000 description 17
- 229920002125 Sokalan® Polymers 0.000 description 16
- 229920002670 Fructan Polymers 0.000 description 15
- 238000011156 evaluation Methods 0.000 description 15
- ZFTFOHBYVDOAMH-XNOIKFDKSA-N (2r,3s,4s,5r)-5-[[(2r,3s,4s,5r)-5-[[(2r,3s,4s,5r)-3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxymethyl]-3,4-dihydroxy-2-(hydroxymethyl)oxolan-2-yl]oxymethyl]-2-(hydroxymethyl)oxolane-2,3,4-triol Chemical class O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@@H]1[C@@H](O)[C@H](O)[C@](CO)(OC[C@@H]2[C@H]([C@H](O)[C@@](O)(CO)O2)O)O1 ZFTFOHBYVDOAMH-XNOIKFDKSA-N 0.000 description 14
- 229920000926 Galactomannan Polymers 0.000 description 14
- 229940071826 hydroxyethyl cellulose Drugs 0.000 description 14
- 210000001519 tissue Anatomy 0.000 description 14
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 12
- 229920002907 Guar gum Polymers 0.000 description 12
- 125000004432 carbon atom Chemical group C* 0.000 description 12
- 238000009472 formulation Methods 0.000 description 12
- 239000000665 guar gum Substances 0.000 description 12
- 235000010417 guar gum Nutrition 0.000 description 12
- 229960002154 guar gum Drugs 0.000 description 12
- 229920000591 gum Polymers 0.000 description 12
- 239000007788 liquid Substances 0.000 description 12
- 229940023476 agar Drugs 0.000 description 11
- 239000000839 emulsion Substances 0.000 description 11
- 230000001815 facial effect Effects 0.000 description 11
- 239000000843 powder Substances 0.000 description 11
- 239000000243 solution Substances 0.000 description 11
- 229920002307 Dextran Polymers 0.000 description 10
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 10
- 229920001202 Inulin Polymers 0.000 description 10
- 125000000129 anionic group Chemical group 0.000 description 10
- 239000001768 carboxy methyl cellulose Substances 0.000 description 10
- 229920001577 copolymer Polymers 0.000 description 10
- 230000000694 effects Effects 0.000 description 10
- 229940029339 inulin Drugs 0.000 description 10
- 235000010420 locust bean gum Nutrition 0.000 description 10
- 229940083542 sodium Drugs 0.000 description 10
- 235000015424 sodium Nutrition 0.000 description 10
- 229960002086 dextran Drugs 0.000 description 9
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 description 9
- 229920001285 xanthan gum Polymers 0.000 description 9
- WQZGKKKJIJFFOK-SVZMEOIVSA-N (+)-Galactose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-SVZMEOIVSA-N 0.000 description 8
- OMDQUFIYNPYJFM-XKDAHURESA-N (2r,3r,4s,5r,6s)-2-(hydroxymethyl)-6-[[(2r,3s,4r,5s,6r)-4,5,6-trihydroxy-3-[(2s,3s,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]methoxy]oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O[C@H]2[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)[C@H](O)[C@H](O)[C@H](O)O1 OMDQUFIYNPYJFM-XKDAHURESA-N 0.000 description 8
- 229920000161 Locust bean gum Polymers 0.000 description 8
- 229920001218 Pullulan Polymers 0.000 description 8
- 239000004373 Pullulan Substances 0.000 description 8
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 8
- 150000007513 acids Chemical class 0.000 description 8
- 125000000217 alkyl group Chemical group 0.000 description 8
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical group OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 8
- 239000000711 locust bean gum Substances 0.000 description 8
- 229920000609 methyl cellulose Polymers 0.000 description 8
- 239000001923 methylcellulose Substances 0.000 description 8
- 229960002900 methylcellulose Drugs 0.000 description 8
- 229960003975 potassium Drugs 0.000 description 8
- 235000019423 pullulan Nutrition 0.000 description 8
- 235000010493 xanthan gum Nutrition 0.000 description 8
- 239000000230 xanthan gum Substances 0.000 description 8
- 229940082509 xanthan gum Drugs 0.000 description 8
- 241000512259 Ascophyllum nodosum Species 0.000 description 7
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 7
- 241000195493 Cryptophyta Species 0.000 description 7
- 239000007864 aqueous solution Substances 0.000 description 7
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 7
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 7
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 7
- 229920003086 cellulose ether Polymers 0.000 description 7
- 150000001875 compounds Chemical class 0.000 description 7
- 238000005886 esterification reaction Methods 0.000 description 7
- 235000010981 methylcellulose Nutrition 0.000 description 7
- 230000004048 modification Effects 0.000 description 7
- 238000012986 modification Methods 0.000 description 7
- 229920000728 polyester Polymers 0.000 description 7
- 238000002360 preparation method Methods 0.000 description 7
- FEBUJFMRSBAMES-UHFFFAOYSA-N 2-[(2-{[3,5-dihydroxy-2-(hydroxymethyl)-6-phosphanyloxan-4-yl]oxy}-3,5-dihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-4-yl)oxy]-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl phosphinite Chemical compound OC1C(O)C(O)C(CO)OC1OCC1C(O)C(OC2C(C(OP)C(O)C(CO)O2)O)C(O)C(OC2C(C(CO)OC(P)C2O)O)O1 FEBUJFMRSBAMES-UHFFFAOYSA-N 0.000 description 6
- 241000196324 Embryophyta Species 0.000 description 6
- 229920002581 Glucomannan Polymers 0.000 description 6
- 229920002752 Konjac Polymers 0.000 description 6
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 6
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 6
- 229920002305 Schizophyllan Polymers 0.000 description 6
- 230000008901 benefit Effects 0.000 description 6
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 239000002537 cosmetic Substances 0.000 description 6
- 230000032050 esterification Effects 0.000 description 6
- 229930182830 galactose Natural products 0.000 description 6
- 229960003082 galactose Drugs 0.000 description 6
- 229940014041 hyaluronate Drugs 0.000 description 6
- 230000036571 hydration Effects 0.000 description 6
- 238000006703 hydration reaction Methods 0.000 description 6
- 229920013821 hydroxy alkyl cellulose Polymers 0.000 description 6
- 229920000151 polyglycol Polymers 0.000 description 6
- 239000010695 polyglycol Substances 0.000 description 6
- LNAZSHAWQACDHT-XIYTZBAFSA-N (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 description 5
- WCDDVEOXEIYWFB-VXORFPGASA-N (2s,3s,4r,5r,6r)-3-[(2s,3r,5s,6r)-3-acetamido-5-hydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4,5,6-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@@H]1C[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](C(O)=O)O[C@@H](O)[C@H](O)[C@H]1O WCDDVEOXEIYWFB-VXORFPGASA-N 0.000 description 5
- OVSKIKFHRZPJSS-UHFFFAOYSA-N 2,4-D Chemical compound OC(=O)COC1=CC=C(Cl)C=C1Cl OVSKIKFHRZPJSS-UHFFFAOYSA-N 0.000 description 5
- 229920000536 2-Acrylamido-2-methylpropane sulfonic acid Polymers 0.000 description 5
- XHZPRMZZQOIPDS-UHFFFAOYSA-N 2-Methyl-2-[(1-oxo-2-propenyl)amino]-1-propanesulfonic acid Chemical compound OS(=O)(=O)CC(C)(C)NC(=O)C=C XHZPRMZZQOIPDS-UHFFFAOYSA-N 0.000 description 5
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 5
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 5
- 241000282372 Panthera onca Species 0.000 description 5
- 241000199919 Phaeophyceae Species 0.000 description 5
- 235000010489 acacia gum Nutrition 0.000 description 5
- 235000011132 calcium sulphate Nutrition 0.000 description 5
- 229960000633 dextran sulfate Drugs 0.000 description 5
- 230000007062 hydrolysis Effects 0.000 description 5
- 238000006460 hydrolysis reaction Methods 0.000 description 5
- 239000002245 particle Substances 0.000 description 5
- 235000011083 sodium citrates Nutrition 0.000 description 5
- 235000000346 sugar Nutrition 0.000 description 5
- 230000009466 transformation Effects 0.000 description 5
- BANXPJUEBPWEOT-UHFFFAOYSA-N 2-methyl-Pentadecane Chemical compound CCCCCCCCCCCCCC(C)C BANXPJUEBPWEOT-UHFFFAOYSA-N 0.000 description 4
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 4
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 4
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 4
- 235000013912 Ceratonia siliqua Nutrition 0.000 description 4
- 240000008886 Ceratonia siliqua Species 0.000 description 4
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 4
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 4
- 229920000084 Gum arabic Polymers 0.000 description 4
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 4
- 241001598113 Laminaria digitata Species 0.000 description 4
- GOOHAUXETOMSMM-UHFFFAOYSA-N Propylene oxide Chemical compound CC1CO1 GOOHAUXETOMSMM-UHFFFAOYSA-N 0.000 description 4
- LCTONWCANYUPML-UHFFFAOYSA-N Pyruvic acid Chemical group CC(=O)C(O)=O LCTONWCANYUPML-UHFFFAOYSA-N 0.000 description 4
- 241000206572 Rhodophyta Species 0.000 description 4
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 4
- 239000000205 acacia gum Substances 0.000 description 4
- 239000000061 acid fraction Substances 0.000 description 4
- PNNNRSAQSRJVSB-BXKVDMCESA-N aldehydo-L-rhamnose Chemical compound C[C@H](O)[C@H](O)[C@@H](O)[C@@H](O)C=O PNNNRSAQSRJVSB-BXKVDMCESA-N 0.000 description 4
- 229920013820 alkyl cellulose Polymers 0.000 description 4
- AEMOLEFTQBMNLQ-WAXACMCWSA-N alpha-D-glucuronic acid Chemical compound O[C@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-WAXACMCWSA-N 0.000 description 4
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 4
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 4
- 238000001035 drying Methods 0.000 description 4
- 150000002170 ethers Chemical class 0.000 description 4
- 238000000855 fermentation Methods 0.000 description 4
- 230000004151 fermentation Effects 0.000 description 4
- 229960005150 glycerol Drugs 0.000 description 4
- 239000008187 granular material Substances 0.000 description 4
- 125000002768 hydroxyalkyl group Chemical group 0.000 description 4
- 239000004615 ingredient Substances 0.000 description 4
- 150000002500 ions Chemical class 0.000 description 4
- 239000000252 konjac Substances 0.000 description 4
- 125000000311 mannosyl group Chemical group C1([C@@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 4
- 229920002401 polyacrylamide Polymers 0.000 description 4
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 4
- 229920006395 saturated elastomer Polymers 0.000 description 4
- 235000010491 tara gum Nutrition 0.000 description 4
- 239000000213 tara gum Substances 0.000 description 4
- LUEWUZLMQUOBSB-FSKGGBMCSA-N (2s,3s,4s,5s,6r)-2-[(2r,3s,4r,5r,6s)-6-[(2r,3s,4r,5s,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5s,6r)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@@H](O[C@@H]2[C@H](O[C@@H](OC3[C@H](O[C@@H](O)[C@@H](O)[C@H]3O)CO)[C@@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O LUEWUZLMQUOBSB-FSKGGBMCSA-N 0.000 description 3
- OYINQIKIQCNQOX-UHFFFAOYSA-M 2-hydroxybutyl(trimethyl)azanium;chloride Chemical compound [Cl-].CCC(O)C[N+](C)(C)C OYINQIKIQCNQOX-UHFFFAOYSA-M 0.000 description 3
- IRLPACMLTUPBCL-KQYNXXCUSA-N 5'-adenylyl sulfate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(=O)OS(O)(=O)=O)[C@@H](O)[C@H]1O IRLPACMLTUPBCL-KQYNXXCUSA-N 0.000 description 3
- 241001474374 Blennius Species 0.000 description 3
- 125000002353 D-glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 3
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 239000001856 Ethyl cellulose Substances 0.000 description 3
- 241000227647 Fucus vesiculosus Species 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- 229920002683 Glycosaminoglycan Polymers 0.000 description 3
- 229920000869 Homopolysaccharide Polymers 0.000 description 3
- PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 description 3
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 3
- OVRNDRQMDRJTHS-FMDGEEDCSA-N N-acetyl-beta-D-glucosamine Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-FMDGEEDCSA-N 0.000 description 3
- 239000000020 Nitrocellulose Substances 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 229920001615 Tragacanth Polymers 0.000 description 3
- FJWGYAHXMCUOOM-QHOUIDNNSA-N [(2s,3r,4s,5r,6r)-2-[(2r,3r,4s,5r,6s)-4,5-dinitrooxy-2-(nitrooxymethyl)-6-[(2r,3r,4s,5r,6s)-4,5,6-trinitrooxy-2-(nitrooxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-3,5-dinitrooxy-6-(nitrooxymethyl)oxan-4-yl] nitrate Chemical compound O([C@@H]1O[C@@H]([C@H]([C@H](O[N+]([O-])=O)[C@H]1O[N+]([O-])=O)O[C@H]1[C@@H]([C@@H](O[N+]([O-])=O)[C@H](O[N+]([O-])=O)[C@@H](CO[N+]([O-])=O)O1)O[N+]([O-])=O)CO[N+](=O)[O-])[C@@H]1[C@@H](CO[N+]([O-])=O)O[C@@H](O[N+]([O-])=O)[C@H](O[N+]([O-])=O)[C@H]1O[N+]([O-])=O FJWGYAHXMCUOOM-QHOUIDNNSA-N 0.000 description 3
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 3
- IAJILQKETJEXLJ-QTBDOELSSA-N aldehydo-D-glucuronic acid Chemical compound O=C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C(O)=O IAJILQKETJEXLJ-QTBDOELSSA-N 0.000 description 3
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 3
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 3
- 229920000617 arabinoxylan Polymers 0.000 description 3
- 150000004783 arabinoxylans Chemical class 0.000 description 3
- 239000000305 astragalus gummifer gum Substances 0.000 description 3
- 150000001720 carbohydrates Chemical class 0.000 description 3
- 229910052799 carbon Inorganic materials 0.000 description 3
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 3
- 150000002016 disaccharides Chemical group 0.000 description 3
- 239000006185 dispersion Substances 0.000 description 3
- 238000009826 distribution Methods 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N ethylene glycol Natural products OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- BJHIKXHVCXFQLS-UYFOZJQFSA-N fructose group Chemical group OCC(=O)[C@@H](O)[C@H](O)[C@H](O)CO BJHIKXHVCXFQLS-UYFOZJQFSA-N 0.000 description 3
- 229940046240 glucomannan Drugs 0.000 description 3
- 229940097043 glucuronic acid Drugs 0.000 description 3
- 229940093915 gynecological organic acid Drugs 0.000 description 3
- 229920003063 hydroxymethyl cellulose Polymers 0.000 description 3
- 229940031574 hydroxymethyl cellulose Drugs 0.000 description 3
- 235000019823 konjac gum Nutrition 0.000 description 3
- 230000000813 microbial effect Effects 0.000 description 3
- 244000005700 microbiome Species 0.000 description 3
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 3
- 239000011859 microparticle Substances 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 230000003020 moisturizing effect Effects 0.000 description 3
- 229950006780 n-acetylglucosamine Drugs 0.000 description 3
- 229920001220 nitrocellulos Polymers 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 235000005985 organic acids Nutrition 0.000 description 3
- 125000000913 palmityl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 3
- 229960004838 phosphoric acid Drugs 0.000 description 3
- 238000006116 polymerization reaction Methods 0.000 description 3
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 3
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 3
- 229920001451 polypropylene glycol Polymers 0.000 description 3
- 229940068968 polysorbate 80 Drugs 0.000 description 3
- 229920000053 polysorbate 80 Polymers 0.000 description 3
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 3
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 3
- 150000008163 sugars Chemical class 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- 229940104261 taurate Drugs 0.000 description 3
- HRXKRNGNAMMEHJ-UHFFFAOYSA-K trisodium citrate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O HRXKRNGNAMMEHJ-UHFFFAOYSA-K 0.000 description 3
- 235000019263 trisodium citrate Nutrition 0.000 description 3
- 229940038773 trisodium citrate Drugs 0.000 description 3
- 238000005303 weighing Methods 0.000 description 3
- 229920001221 xylan Polymers 0.000 description 3
- 150000004823 xylans Chemical class 0.000 description 3
- FYGDTMLNYKFZSV-BYLHFPJWSA-N β-1,4-galactotrioside Chemical group O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@H](CO)O[C@@H](O[C@@H]2[C@@H](O[C@@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-BYLHFPJWSA-N 0.000 description 3
- VCVKIIDXVWEWSZ-YFKPBYRVSA-N (2s)-2-[bis(carboxymethyl)amino]pentanedioic acid Chemical compound OC(=O)CC[C@@H](C(O)=O)N(CC(O)=O)CC(O)=O VCVKIIDXVWEWSZ-YFKPBYRVSA-N 0.000 description 2
- AEMOLEFTQBMNLQ-SYJWYVCOSA-N (2s,3s,4s,5s,6r)-3,4,5,6-tetrahydroxyoxane-2-carboxylic acid Chemical compound O[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@@H]1O AEMOLEFTQBMNLQ-SYJWYVCOSA-N 0.000 description 2
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 2
- 229940043268 2,2,4,4,6,8,8-heptamethylnonane Drugs 0.000 description 2
- OWPUOLBODXJOKH-UHFFFAOYSA-N 2,3-dihydroxypropyl prop-2-enoate Chemical compound OCC(O)COC(=O)C=C OWPUOLBODXJOKH-UHFFFAOYSA-N 0.000 description 2
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 2
- DWHIUNMOTRUVPG-UHFFFAOYSA-N 2-[2-[2-[2-[2-[2-(2-dodecoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethanol Chemical compound CCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCO DWHIUNMOTRUVPG-UHFFFAOYSA-N 0.000 description 2
- URDCARMUOSMFFI-UHFFFAOYSA-N 2-[2-[bis(carboxymethyl)amino]ethyl-(2-hydroxyethyl)amino]acetic acid Chemical compound OCCN(CC(O)=O)CCN(CC(O)=O)CC(O)=O URDCARMUOSMFFI-UHFFFAOYSA-N 0.000 description 2
- GHPVDCPCKSNJDR-UHFFFAOYSA-N 2-hydroxydecanoic acid Chemical compound CCCCCCCCC(O)C(O)=O GHPVDCPCKSNJDR-UHFFFAOYSA-N 0.000 description 2
- YDZIJQXINJLRLL-UHFFFAOYSA-N 2-hydroxydodecanoic acid Chemical compound CCCCCCCCCCC(O)C(O)=O YDZIJQXINJLRLL-UHFFFAOYSA-N 0.000 description 2
- SVTBMSDMJJWYQN-UHFFFAOYSA-N 2-methylpentane-2,4-diol Chemical compound CC(O)CC(C)(C)O SVTBMSDMJJWYQN-UHFFFAOYSA-N 0.000 description 2
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 2
- AACHVWXCVWWMSI-UHFFFAOYSA-N 3-hydroxypropyl(trimethyl)azanium Chemical compound C[N+](C)(C)CCCO AACHVWXCVWWMSI-UHFFFAOYSA-N 0.000 description 2
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 2
- 244000215068 Acacia senegal Species 0.000 description 2
- 229920002126 Acrylic acid copolymer Polymers 0.000 description 2
- 244000247812 Amorphophallus rivieri Species 0.000 description 2
- 235000001206 Amorphophallus rivieri Nutrition 0.000 description 2
- 240000002900 Arthrospira platensis Species 0.000 description 2
- 235000016425 Arthrospira platensis Nutrition 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 235000017166 Bambusa arundinacea Nutrition 0.000 description 2
- 235000017491 Bambusa tulda Nutrition 0.000 description 2
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 2
- 229920003043 Cellulose fiber Polymers 0.000 description 2
- 229920002101 Chitin Polymers 0.000 description 2
- 229920001661 Chitosan Polymers 0.000 description 2
- 229920001287 Chondroitin sulfate Polymers 0.000 description 2
- 244000298479 Cichorium intybus Species 0.000 description 2
- 235000007542 Cichorium intybus Nutrition 0.000 description 2
- 102000008186 Collagen Human genes 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 2
- 229930091371 Fructose Natural products 0.000 description 2
- 239000005715 Fructose Substances 0.000 description 2
- 229920001503 Glucan Polymers 0.000 description 2
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
- 240000008892 Helianthus tuberosus Species 0.000 description 2
- 235000003230 Helianthus tuberosus Nutrition 0.000 description 2
- MLSJBGYKDYSOAE-DCWMUDTNSA-N L-Ascorbic acid-2-glucoside Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)=C1O MLSJBGYKDYSOAE-DCWMUDTNSA-N 0.000 description 2
- SRBFZHDQGSBBOR-HWQSCIPKSA-N L-arabinopyranose Chemical compound O[C@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-HWQSCIPKSA-N 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- 229920000057 Mannan Polymers 0.000 description 2
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical group OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 2
- 239000004909 Moisturizer Substances 0.000 description 2
- FSVCELGFZIQNCK-UHFFFAOYSA-N N,N-bis(2-hydroxyethyl)glycine Chemical compound OCCN(CCO)CC(O)=O FSVCELGFZIQNCK-UHFFFAOYSA-N 0.000 description 2
- OVRNDRQMDRJTHS-UHFFFAOYSA-N N-acelyl-D-glucosamine Natural products CC(=O)NC1C(O)OC(CO)C(O)C1O OVRNDRQMDRJTHS-UHFFFAOYSA-N 0.000 description 2
- 239000005642 Oleic acid Substances 0.000 description 2
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- 244000082204 Phyllostachys viridis Species 0.000 description 2
- 235000015334 Phyllostachys viridis Nutrition 0.000 description 2
- IMQLKJBTEOYOSI-UHFFFAOYSA-N Phytic acid Natural products OP(O)(=O)OC1C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C1OP(O)(O)=O IMQLKJBTEOYOSI-UHFFFAOYSA-N 0.000 description 2
- 229920002845 Poly(methacrylic acid) Polymers 0.000 description 2
- 239000004698 Polyethylene Substances 0.000 description 2
- 241001428125 Polyideaceae Species 0.000 description 2
- 239000004743 Polypropylene Substances 0.000 description 2
- VYGQUTWHTHXGQB-FFHKNEKCSA-N Retinol Palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-FFHKNEKCSA-N 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 235000021355 Stearic acid Nutrition 0.000 description 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 2
- 241000589636 Xanthomonas campestris Species 0.000 description 2
- 210000001015 abdomen Anatomy 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 150000001252 acrylic acid derivatives Chemical class 0.000 description 2
- 125000002877 alkyl aryl group Chemical group 0.000 description 2
- 150000005215 alkyl ethers Chemical class 0.000 description 2
- 238000005804 alkylation reaction Methods 0.000 description 2
- 125000002947 alkylene group Chemical group 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- 150000001280 alpha hydroxy acids Chemical class 0.000 description 2
- AEMOLEFTQBMNLQ-BKBMJHBISA-N alpha-D-galacturonic acid Chemical compound O[C@H]1O[C@H](C(O)=O)[C@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-BKBMJHBISA-N 0.000 description 2
- AEMOLEFTQBMNLQ-ORELYVPDSA-N alpha-L-glucopyranuronic acid Chemical compound O[C@@H]1O[C@@H](C(O)=O)[C@H](O)[C@@H](O)[C@@H]1O AEMOLEFTQBMNLQ-ORELYVPDSA-N 0.000 description 2
- 230000009435 amidation Effects 0.000 description 2
- 238000007112 amidation reaction Methods 0.000 description 2
- 238000005576 amination reaction Methods 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 229940035674 anesthetics Drugs 0.000 description 2
- 150000001450 anions Chemical class 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 239000012736 aqueous medium Substances 0.000 description 2
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 2
- 125000003710 aryl alkyl group Chemical group 0.000 description 2
- 229940067599 ascorbyl glucoside Drugs 0.000 description 2
- 239000011425 bamboo Substances 0.000 description 2
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 2
- 150000001277 beta hydroxy acids Chemical class 0.000 description 2
- 229920001222 biopolymer Polymers 0.000 description 2
- 239000007844 bleaching agent Substances 0.000 description 2
- 239000006227 byproduct Substances 0.000 description 2
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 2
- 239000004202 carbamide Substances 0.000 description 2
- 229960001631 carbomer Drugs 0.000 description 2
- 125000002843 carboxylic acid group Chemical group 0.000 description 2
- 150000001735 carboxylic acids Chemical class 0.000 description 2
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 2
- 229920003090 carboxymethyl hydroxyethyl cellulose Polymers 0.000 description 2
- 210000002421 cell wall Anatomy 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 229960005188 collagen Drugs 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- 229910000365 copper sulfate Inorganic materials 0.000 description 2
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 description 2
- 229920006037 cross link polymer Polymers 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 239000007854 depigmenting agent Substances 0.000 description 2
- RXKJFZQQPQGTFL-UHFFFAOYSA-N dihydroxyacetone Chemical compound OCC(=O)CO RXKJFZQQPQGTFL-UHFFFAOYSA-N 0.000 description 2
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000006266 etherification reaction Methods 0.000 description 2
- 235000019325 ethyl cellulose Nutrition 0.000 description 2
- 229920001249 ethyl cellulose Polymers 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 239000000451 gelidium spp. gum Substances 0.000 description 2
- 239000003193 general anesthetic agent Substances 0.000 description 2
- 239000003292 glue Substances 0.000 description 2
- 238000000227 grinding Methods 0.000 description 2
- 230000000887 hydrating effect Effects 0.000 description 2
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 2
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 2
- KUVMKLCGXIYSNH-UHFFFAOYSA-N isopentadecane Natural products CCCCCCCCCCCCC(C)C KUVMKLCGXIYSNH-UHFFFAOYSA-N 0.000 description 2
- 235000010485 konjac Nutrition 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 229940031674 laureth-7 Drugs 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- GRVDJDISBSALJP-UHFFFAOYSA-N methyloxidanyl Chemical group [O]C GRVDJDISBSALJP-UHFFFAOYSA-N 0.000 description 2
- 239000008108 microcrystalline cellulose Substances 0.000 description 2
- 229940016286 microcrystalline cellulose Drugs 0.000 description 2
- 238000003801 milling Methods 0.000 description 2
- 150000007522 mineralic acids Chemical class 0.000 description 2
- 230000001333 moisturizer Effects 0.000 description 2
- 239000000178 monomer Substances 0.000 description 2
- YLGYACDQVQQZSW-UHFFFAOYSA-N n,n-dimethylprop-2-enamide Chemical compound CN(C)C(=O)C=C YLGYACDQVQQZSW-UHFFFAOYSA-N 0.000 description 2
- 239000005445 natural material Substances 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- BDJRBEYXGGNYIS-UHFFFAOYSA-N nonanedioic acid Chemical compound OC(=O)CCCCCCCC(O)=O BDJRBEYXGGNYIS-UHFFFAOYSA-N 0.000 description 2
- 239000007764 o/w emulsion Substances 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 2
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 2
- 235000006408 oxalic acid Nutrition 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
- 239000010452 phosphate Substances 0.000 description 2
- 230000026731 phosphorylation Effects 0.000 description 2
- 238000006366 phosphorylation reaction Methods 0.000 description 2
- 229940068041 phytic acid Drugs 0.000 description 2
- 239000000467 phytic acid Substances 0.000 description 2
- 229920000573 polyethylene Polymers 0.000 description 2
- 229920000139 polyethylene terephthalate Polymers 0.000 description 2
- 239000005020 polyethylene terephthalate Substances 0.000 description 2
- 239000010318 polygalacturonic acid Substances 0.000 description 2
- 229920001155 polypropylene Polymers 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 229960004889 salicylic acid Drugs 0.000 description 2
- 150000004671 saturated fatty acids Chemical class 0.000 description 2
- 230000035807 sensation Effects 0.000 description 2
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 2
- 235000012239 silicon dioxide Nutrition 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 229940082787 spirulina Drugs 0.000 description 2
- 238000005507 spraying Methods 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000008117 stearic acid Substances 0.000 description 2
- UBXAKNTVXQMEAG-UHFFFAOYSA-L strontium sulfate Chemical compound [Sr+2].[O-]S([O-])(=O)=O UBXAKNTVXQMEAG-UHFFFAOYSA-L 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 230000019635 sulfation Effects 0.000 description 2
- 238000005670 sulfation reaction Methods 0.000 description 2
- 229910052717 sulfur Inorganic materials 0.000 description 2
- 239000011593 sulfur Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 229920002994 synthetic fiber Polymers 0.000 description 2
- 239000012209 synthetic fiber Substances 0.000 description 2
- 239000011975 tartaric acid Substances 0.000 description 2
- 235000002906 tartaric acid Nutrition 0.000 description 2
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 2
- UEUXEKPTXMALOB-UHFFFAOYSA-J tetrasodium;2-[2-[bis(carboxylatomethyl)amino]ethyl-(carboxylatomethyl)amino]acetate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]C(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O UEUXEKPTXMALOB-UHFFFAOYSA-J 0.000 description 2
- 230000000699 topical effect Effects 0.000 description 2
- 238000011282 treatment Methods 0.000 description 2
- 125000005208 trialkylammonium group Chemical group 0.000 description 2
- PUVAFTRIIUSGLK-UHFFFAOYSA-M trimethyl(oxiran-2-ylmethyl)azanium;chloride Chemical compound [Cl-].C[N+](C)(C)CC1CO1 PUVAFTRIIUSGLK-UHFFFAOYSA-M 0.000 description 2
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 2
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 2
- JOYRKODLDBILNP-UHFFFAOYSA-N urethane group Chemical group NC(=O)OCC JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 239000000341 volatile oil Substances 0.000 description 2
- 239000002759 woven fabric Substances 0.000 description 2
- WTVHAMTYZJGJLJ-UHFFFAOYSA-N (+)-(4S,8R)-8-epi-beta-bisabolol Natural products CC(C)=CCCC(C)C1(O)CCC(C)=CC1 WTVHAMTYZJGJLJ-UHFFFAOYSA-N 0.000 description 1
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 1
- RGZSQWQPBWRIAQ-CABCVRRESA-N (-)-alpha-Bisabolol Chemical compound CC(C)=CCC[C@](C)(O)[C@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-CABCVRRESA-N 0.000 description 1
- QBYIENPQHBMVBV-HFEGYEGKSA-N (2R)-2-hydroxy-2-phenylacetic acid Chemical compound O[C@@H](C(O)=O)c1ccccc1.O[C@@H](C(O)=O)c1ccccc1 QBYIENPQHBMVBV-HFEGYEGKSA-N 0.000 description 1
- DBSABEYSGXPBTA-RXSVEWSESA-N (2r)-2-[(1s)-1,2-dihydroxyethyl]-3,4-dihydroxy-2h-furan-5-one;phosphoric acid Chemical compound OP(O)(O)=O.OC[C@H](O)[C@H]1OC(=O)C(O)=C1O DBSABEYSGXPBTA-RXSVEWSESA-N 0.000 description 1
- FYGDTMLNYKFZSV-WFYNLLPOSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,3s,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical group O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](O[C@@H]2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-WFYNLLPOSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- 229940043375 1,5-pentanediol Drugs 0.000 description 1
- FZWBNHMXJMCXLU-UHFFFAOYSA-N 2,3,4,5-tetrahydroxy-6-[3,4,5-trihydroxy-6-[[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxyhexanal Chemical compound OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OCC(O)C(O)C(O)C(O)C=O)O1 FZWBNHMXJMCXLU-UHFFFAOYSA-N 0.000 description 1
- LCZVSXRMYJUNFX-UHFFFAOYSA-N 2-[2-(2-hydroxypropoxy)propoxy]propan-1-ol Chemical compound CC(O)COC(C)COC(C)CO LCZVSXRMYJUNFX-UHFFFAOYSA-N 0.000 description 1
- IXIGWKNBFPKCCD-UHFFFAOYSA-N 2-hydroxy-5-octanoylbenzoic acid Chemical compound CCCCCCCC(=O)C1=CC=C(O)C(C(O)=O)=C1 IXIGWKNBFPKCCD-UHFFFAOYSA-N 0.000 description 1
- AFENDNXGAFYKQO-UHFFFAOYSA-N 2-hydroxybutyric acid Chemical compound CCC(O)C(O)=O AFENDNXGAFYKQO-UHFFFAOYSA-N 0.000 description 1
- OMIGHNLMNHATMP-UHFFFAOYSA-N 2-hydroxyethyl prop-2-enoate Chemical compound OCCOC(=O)C=C OMIGHNLMNHATMP-UHFFFAOYSA-N 0.000 description 1
- BWLBGMIXKSTLSX-UHFFFAOYSA-N 2-hydroxyisobutyric acid Chemical compound CC(C)(O)C(O)=O BWLBGMIXKSTLSX-UHFFFAOYSA-N 0.000 description 1
- UOQHWNPVNXSDDO-UHFFFAOYSA-N 3-bromoimidazo[1,2-a]pyridine-6-carbonitrile Chemical compound C1=CC(C#N)=CN2C(Br)=CN=C21 UOQHWNPVNXSDDO-UHFFFAOYSA-N 0.000 description 1
- VFKZECOCJCGZQK-UHFFFAOYSA-M 3-hydroxypropyl(trimethyl)azanium;chloride Chemical compound [Cl-].C[N+](C)(C)CCCO VFKZECOCJCGZQK-UHFFFAOYSA-M 0.000 description 1
- DBTMGCOVALSLOR-UHFFFAOYSA-N 32-alpha-galactosyl-3-alpha-galactosyl-galactose Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(OC2C(C(CO)OC(O)C2O)O)OC(CO)C1O DBTMGCOVALSLOR-UHFFFAOYSA-N 0.000 description 1
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical group CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- 241000199897 Alaria esculenta Species 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- 229920000945 Amylopectin Polymers 0.000 description 1
- 229920000856 Amylose Polymers 0.000 description 1
- 241000042983 Anacolosa clarkii Species 0.000 description 1
- 244000106483 Anogeissus latifolia Species 0.000 description 1
- 235000011514 Anogeissus latifolia Nutrition 0.000 description 1
- 229920000189 Arabinogalactan Polymers 0.000 description 1
- 241000209524 Araceae Species 0.000 description 1
- 239000004342 Benzoyl peroxide Substances 0.000 description 1
- OMPJBNCRMGITSC-UHFFFAOYSA-N Benzoylperoxide Chemical compound C=1C=CC=CC=1C(=O)OOC(=O)C1=CC=CC=C1 OMPJBNCRMGITSC-UHFFFAOYSA-N 0.000 description 1
- 241000219310 Beta vulgaris subsp. vulgaris Species 0.000 description 1
- 125000006577 C1-C6 hydroxyalkyl group Chemical group 0.000 description 1
- GAWIXWVDTYZWAW-UHFFFAOYSA-N C[CH]O Chemical group C[CH]O GAWIXWVDTYZWAW-UHFFFAOYSA-N 0.000 description 1
- 235000017399 Caesalpinia tinctoria Nutrition 0.000 description 1
- 239000001884 Cassia gum Substances 0.000 description 1
- 229920008347 Cellulose acetate propionate Polymers 0.000 description 1
- 241000561734 Celosia cristata Species 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- QXKAIJAYHKCRRA-JJYYJPOSSA-N D-arabinonic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C(O)=O QXKAIJAYHKCRRA-JJYYJPOSSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- RXVWSYJTUUKTEA-UHFFFAOYSA-N D-maltotriose Natural products OC1C(O)C(OC(C(O)CO)C(O)C(O)C=O)OC(CO)C1OC1C(O)C(O)C(O)C(CO)O1 RXVWSYJTUUKTEA-UHFFFAOYSA-N 0.000 description 1
- 125000000214 D-xylosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)CO1)* 0.000 description 1
- 244000115658 Dahlia pinnata Species 0.000 description 1
- 235000012040 Dahlia pinnata Nutrition 0.000 description 1
- 208000001840 Dandruff Diseases 0.000 description 1
- 229920000045 Dermatan sulfate Polymers 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- 102000016942 Elastin Human genes 0.000 description 1
- 108010014258 Elastin Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 229920000896 Ethulose Polymers 0.000 description 1
- 239000001859 Ethyl hydroxyethyl cellulose Substances 0.000 description 1
- 235000016623 Fragaria vesca Nutrition 0.000 description 1
- 240000009088 Fragaria x ananassa Species 0.000 description 1
- 235000011363 Fragaria x ananassa Nutrition 0.000 description 1
- 241000004455 Fucus spiralis Species 0.000 description 1
- 241001134786 Furcellaria Species 0.000 description 1
- 241001134784 Furcellariaceae Species 0.000 description 1
- 241000206672 Gelidium Species 0.000 description 1
- 229920001706 Glucuronoxylan Polymers 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- 235000017367 Guainella Nutrition 0.000 description 1
- 239000001922 Gum ghatti Substances 0.000 description 1
- 229920000569 Gum karaya Polymers 0.000 description 1
- 229920002488 Hemicellulose Polymers 0.000 description 1
- 241001428260 Hypneaceae Species 0.000 description 1
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 1
- 229920000288 Keratan sulfate Polymers 0.000 description 1
- 238000007696 Kjeldahl method Methods 0.000 description 1
- PWKSKIMOESPYIA-BYPYZUCNSA-N L-N-acetyl-Cysteine Chemical compound CC(=O)N[C@@H](CS)C(O)=O PWKSKIMOESPYIA-BYPYZUCNSA-N 0.000 description 1
- NGEWQZIDQIYUNV-UHFFFAOYSA-N L-valinic acid Natural products CC(C)C(O)C(O)=O NGEWQZIDQIYUNV-UHFFFAOYSA-N 0.000 description 1
- 241001466453 Laminaria Species 0.000 description 1
- 241000296380 Laminaria hyperborea Species 0.000 description 1
- 241001512709 Lessonia <stramenopiles> Species 0.000 description 1
- 241001260563 Lessonia nigrescens Species 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- 102220549062 Low molecular weight phosphotyrosine protein phosphatase_C13S_mutation Human genes 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 description 1
- 229920003091 Methocel™ Polymers 0.000 description 1
- QPCDCPDFJACHGM-UHFFFAOYSA-N N,N-bis{2-[bis(carboxymethyl)amino]ethyl}glycine Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(=O)O)CCN(CC(O)=O)CC(O)=O QPCDCPDFJACHGM-UHFFFAOYSA-N 0.000 description 1
- 125000003047 N-acetyl group Chemical group 0.000 description 1
- MBLBDJOUHNCFQT-LXGUWJNJSA-N N-acetylglucosamine Natural products CC(=O)N[C@@H](C=O)[C@@H](O)[C@H](O)[C@H](O)CO MBLBDJOUHNCFQT-LXGUWJNJSA-N 0.000 description 1
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 1
- REYJJPSVUYRZGE-UHFFFAOYSA-N Octadecylamine Chemical compound CCCCCCCCCCCCCCCCCCN REYJJPSVUYRZGE-UHFFFAOYSA-N 0.000 description 1
- 229920002230 Pectic acid Polymers 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 235000007685 Pleurotus columbinus Nutrition 0.000 description 1
- 240000001462 Pleurotus ostreatus Species 0.000 description 1
- 235000001603 Pleurotus ostreatus Nutrition 0.000 description 1
- HDSBZMRLPLPFLQ-UHFFFAOYSA-N Propylene glycol alginate Chemical compound OC1C(O)C(OC)OC(C(O)=O)C1OC1C(O)C(O)C(C)C(C(=O)OCC(C)O)O1 HDSBZMRLPLPFLQ-UHFFFAOYSA-N 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 101800000789 Protease-polymerase p70 Proteins 0.000 description 1
- 101800000786 Protease-polymerase p76 Proteins 0.000 description 1
- IWYDHOAUDWTVEP-UHFFFAOYSA-N R-2-phenyl-2-hydroxyacetic acid Natural products OC(=O)C(O)C1=CC=CC=C1 IWYDHOAUDWTVEP-UHFFFAOYSA-N 0.000 description 1
- CZMRCDWAGMRECN-UHFFFAOYSA-N Rohrzucker Natural products OCC1OC(CO)(OC2OC(CO)C(O)C(O)C2O)C(O)C1O CZMRCDWAGMRECN-UHFFFAOYSA-N 0.000 description 1
- 241000015177 Saccharina japonica Species 0.000 description 1
- 241000983746 Saccharina latissima Species 0.000 description 1
- 241000195475 Sargassaceae Species 0.000 description 1
- NWGKJDSIEKMTRX-AAZCQSIUSA-N Sorbitan monooleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O NWGKJDSIEKMTRX-AAZCQSIUSA-N 0.000 description 1
- 241000934878 Sterculia Species 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- 235000021536 Sugar beet Nutrition 0.000 description 1
- 241000388430 Tara Species 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical group CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 1
- 244000250129 Trigonella foenum graecum Species 0.000 description 1
- 235000001484 Trigonella foenum graecum Nutrition 0.000 description 1
- 241000251539 Vertebrata <Metazoa> Species 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 229920002000 Xyloglucan Polymers 0.000 description 1
- SFRPDSKECHTFQA-ONOWFSFQSA-N [(2e,4e,6e,8e)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenyl] propanoate Chemical compound CCC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SFRPDSKECHTFQA-ONOWFSFQSA-N 0.000 description 1
- ZNOZWUKQPJXOIG-XSBHQQIPSA-L [(2r,3s,4r,5r,6s)-6-[[(1r,3s,4r,5r,8s)-3,4-dihydroxy-2,6-dioxabicyclo[3.2.1]octan-8-yl]oxy]-4-[[(1r,3r,4r,5r,8s)-8-[(2s,3r,4r,5r,6r)-3,4-dihydroxy-6-(hydroxymethyl)-5-sulfonatooxyoxan-2-yl]oxy-4-hydroxy-2,6-dioxabicyclo[3.2.1]octan-3-yl]oxy]-5-hydroxy-2-( Chemical compound O[C@@H]1[C@@H](O)[C@@H](OS([O-])(=O)=O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H]2OC[C@H]1O[C@H](O[C@H]1[C@H]([C@@H](CO)O[C@@H](O[C@@H]3[C@@H]4OC[C@H]3O[C@H](O)[C@@H]4O)[C@@H]1O)OS([O-])(=O)=O)[C@@H]2O ZNOZWUKQPJXOIG-XSBHQQIPSA-L 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000001785 acacia senegal l. willd gum Substances 0.000 description 1
- UGZICOVULPINFH-UHFFFAOYSA-N acetic acid;butanoic acid Chemical compound CC(O)=O.CCCC(O)=O UGZICOVULPINFH-UHFFFAOYSA-N 0.000 description 1
- SFTWOUGLKLTUDZ-UHFFFAOYSA-N acetic acid;butanoic acid;sulfuric acid Chemical compound CC(O)=O.OS(O)(=O)=O.CCCC(O)=O SFTWOUGLKLTUDZ-UHFFFAOYSA-N 0.000 description 1
- AVMNFQHJOOYCAP-UHFFFAOYSA-N acetic acid;propanoic acid Chemical compound CC(O)=O.CCC(O)=O AVMNFQHJOOYCAP-UHFFFAOYSA-N 0.000 description 1
- DBUBLKKOEROCAH-UHFFFAOYSA-N acetic acid;propanoic acid;sulfuric acid Chemical compound CC(O)=O.CCC(O)=O.OS(O)(=O)=O DBUBLKKOEROCAH-UHFFFAOYSA-N 0.000 description 1
- WDJHALXBUFZDSR-UHFFFAOYSA-N acetoacetic acid Chemical compound CC(=O)CC(O)=O WDJHALXBUFZDSR-UHFFFAOYSA-N 0.000 description 1
- 229960004308 acetylcysteine Drugs 0.000 description 1
- 229920001284 acidic polysaccharide Polymers 0.000 description 1
- 150000004805 acidic polysaccharides Chemical class 0.000 description 1
- 239000003929 acidic solution Substances 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 238000010564 aerobic fermentation Methods 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- IAJILQKETJEXLJ-RSJOWCBRSA-N aldehydo-D-galacturonic acid Chemical compound O=C[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)C(O)=O IAJILQKETJEXLJ-RSJOWCBRSA-N 0.000 description 1
- 150000001335 aliphatic alkanes Chemical class 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 125000005210 alkyl ammonium group Chemical group 0.000 description 1
- 125000005037 alkyl phenyl group Chemical group 0.000 description 1
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- 235000014104 aloe vera supplement Nutrition 0.000 description 1
- RGZSQWQPBWRIAQ-LSDHHAIUSA-N alpha-Bisabolol Natural products CC(C)=CCC[C@@](C)(O)[C@@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-LSDHHAIUSA-N 0.000 description 1
- 125000003550 alpha-D-galactosyl group Chemical group C1([C@H](O)[C@@H](O)[C@@H](O)[C@H](O1)CO)* 0.000 description 1
- WQZGKKKJIJFFOK-PQMKYFCFSA-N alpha-D-mannose Chemical compound OC[C@H]1O[C@H](O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-PQMKYFCFSA-N 0.000 description 1
- AVJBPWGFOQAPRH-FWMKGIEWSA-N alpha-L-IdopA-(1->3)-beta-D-GalpNAc4S Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@H](OS(O)(=O)=O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](C(O)=O)O1 AVJBPWGFOQAPRH-FWMKGIEWSA-N 0.000 description 1
- HMFHBZSHGGEWLO-QMKXCQHVSA-N alpha-L-arabinofuranose Chemical group OC[C@@H]1O[C@@H](O)[C@H](O)[C@H]1O HMFHBZSHGGEWLO-QMKXCQHVSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 235000019824 amidated pectin Nutrition 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 229940035676 analgesics Drugs 0.000 description 1
- 229920006321 anionic cellulose Polymers 0.000 description 1
- 229920001586 anionic polysaccharide Polymers 0.000 description 1
- 150000004836 anionic polysaccharides Chemical class 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- 125000002178 anthracenyl group Chemical group C1(=CC=CC2=CC3=CC=CC=C3C=C12)* 0.000 description 1
- 239000000058 anti acne agent Substances 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003474 anti-emetic effect Effects 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 230000001166 anti-perspirative effect Effects 0.000 description 1
- 230000001139 anti-pruritic effect Effects 0.000 description 1
- 230000001153 anti-wrinkle effect Effects 0.000 description 1
- 230000000656 anti-yeast Effects 0.000 description 1
- 229940124340 antiacne agent Drugs 0.000 description 1
- 239000000924 antiasthmatic agent Substances 0.000 description 1
- 239000002111 antiemetic agent Substances 0.000 description 1
- 229940125683 antiemetic agent Drugs 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 239000003429 antifungal agent Substances 0.000 description 1
- 239000000739 antihistaminic agent Substances 0.000 description 1
- 229940125715 antihistaminic agent Drugs 0.000 description 1
- 239000003213 antiperspirant Substances 0.000 description 1
- 239000003908 antipruritic agent Substances 0.000 description 1
- 229940030999 antipsoriatics Drugs 0.000 description 1
- 239000003443 antiviral agent Substances 0.000 description 1
- 239000007900 aqueous suspension Substances 0.000 description 1
- 235000019312 arabinogalactan Nutrition 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229940071097 ascorbyl phosphate Drugs 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- 239000012752 auxiliary agent Substances 0.000 description 1
- BQMNFPBUAQPINY-UHFFFAOYSA-N azane;2-methyl-2-(prop-2-enoylamino)propane-1-sulfonic acid Chemical compound [NH4+].[O-]S(=O)(=O)CC(C)(C)NC(=O)C=C BQMNFPBUAQPINY-UHFFFAOYSA-N 0.000 description 1
- 229960002255 azelaic acid Drugs 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 125000002511 behenyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 235000019400 benzoyl peroxide Nutrition 0.000 description 1
- 229960003328 benzoyl peroxide Drugs 0.000 description 1
- AEMOLEFTQBMNLQ-QIUUJYRFSA-N beta-D-glucuronic acid Chemical compound O[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-QIUUJYRFSA-N 0.000 description 1
- WQZGKKKJIJFFOK-RWOPYEJCSA-N beta-D-mannose Chemical group OC[C@H]1O[C@@H](O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-RWOPYEJCSA-N 0.000 description 1
- DHCLVCXQIBBOPH-UHFFFAOYSA-N beta-glycerol phosphate Natural products OCC(CO)OP(O)(O)=O DHCLVCXQIBBOPH-UHFFFAOYSA-N 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 229940036350 bisabolol Drugs 0.000 description 1
- HHGZABIIYIWLGA-UHFFFAOYSA-N bisabolol Natural products CC1CCC(C(C)(O)CCC=C(C)C)CC1 HHGZABIIYIWLGA-UHFFFAOYSA-N 0.000 description 1
- 229940124630 bronchodilator Drugs 0.000 description 1
- 239000000168 bronchodilator agent Substances 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 229960001948 caffeine Drugs 0.000 description 1
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 1
- 239000001175 calcium sulphate Substances 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 125000004181 carboxyalkyl group Chemical group 0.000 description 1
- 229920003064 carboxyethyl cellulose Polymers 0.000 description 1
- 229940105329 carboxymethylcellulose Drugs 0.000 description 1
- 235000019318 cassia gum Nutrition 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 125000001547 cellobiose group Chemical group 0.000 description 1
- 229920002301 cellulose acetate Polymers 0.000 description 1
- 229920006217 cellulose acetate butyrate Polymers 0.000 description 1
- 229940106189 ceramide Drugs 0.000 description 1
- 150000001783 ceramides Chemical class 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000007385 chemical modification Methods 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Natural products C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 1
- 229940059329 chondroitin sulfate Drugs 0.000 description 1
- 210000001520 comb Anatomy 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 239000002872 contrast media Substances 0.000 description 1
- 239000013256 coordination polymer Substances 0.000 description 1
- 239000003246 corticosteroid Substances 0.000 description 1
- 229960001334 corticosteroids Drugs 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 239000002781 deodorant agent Substances 0.000 description 1
- 229940051593 dermatan sulfate Drugs 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 229940119743 dextran 70 Drugs 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 229940120503 dihydroxyacetone Drugs 0.000 description 1
- 239000000539 dimer Substances 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- 229940113120 dipropylene glycol Drugs 0.000 description 1
- 239000002526 disodium citrate Substances 0.000 description 1
- 235000019262 disodium citrate Nutrition 0.000 description 1
- CEYULKASIQJZGP-UHFFFAOYSA-L disodium;2-(carboxymethyl)-2-hydroxybutanedioate Chemical compound [Na+].[Na+].[O-]C(=O)CC(O)(C(=O)O)CC([O-])=O CEYULKASIQJZGP-UHFFFAOYSA-L 0.000 description 1
- JRBPAEWTRLWTQC-UHFFFAOYSA-N dodecylamine Chemical compound CCCCCCCCCCCCN JRBPAEWTRLWTQC-UHFFFAOYSA-N 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000037336 dry skin Effects 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 229920002549 elastin Polymers 0.000 description 1
- 230000005684 electric field Effects 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 125000001033 ether group Chemical group 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 235000019326 ethyl hydroxyethyl cellulose Nutrition 0.000 description 1
- 235000010944 ethyl methyl cellulose Nutrition 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 210000001061 forehead Anatomy 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 235000009569 green tea Nutrition 0.000 description 1
- 235000019314 gum ghatti Nutrition 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 239000013003 healing agent Substances 0.000 description 1
- 229940051250 hexylene glycol Drugs 0.000 description 1
- KIUKXJAPPMFGSW-MNSSHETKSA-N hyaluronan Chemical group CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)C1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H](C(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-MNSSHETKSA-N 0.000 description 1
- 150000004677 hydrates Chemical class 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 description 1
- 229920003132 hydroxypropyl methylcellulose phthalate Polymers 0.000 description 1
- 229940031704 hydroxypropyl methylcellulose phthalate Drugs 0.000 description 1
- 229940071676 hydroxypropylcellulose Drugs 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 239000002955 immunomodulating agent Substances 0.000 description 1
- 229940121354 immunomodulator Drugs 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 239000002085 irritant Substances 0.000 description 1
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 1
- 235000010494 karaya gum Nutrition 0.000 description 1
- 239000000231 karaya gum Substances 0.000 description 1
- 229940039371 karaya gum Drugs 0.000 description 1
- KXCLCNHUUKTANI-RBIYJLQWSA-N keratan Chemical compound CC(=O)N[C@@H]1[C@@H](O)C[C@@H](COS(O)(=O)=O)O[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@H](O[C@@H](O[C@H]3[C@H]([C@@H](COS(O)(=O)=O)O[C@@H](O)[C@@H]3O)O)[C@H](NC(C)=O)[C@H]2O)COS(O)(=O)=O)O[C@H](COS(O)(=O)=O)[C@@H]1O KXCLCNHUUKTANI-RBIYJLQWSA-N 0.000 description 1
- 239000003410 keratolytic agent Substances 0.000 description 1
- BEJNERDRQOWKJM-UHFFFAOYSA-N kojic acid Chemical compound OCC1=CC(=O)C(O)=CO1 BEJNERDRQOWKJM-UHFFFAOYSA-N 0.000 description 1
- 229960004705 kojic acid Drugs 0.000 description 1
- WZNJWVWKTVETCG-UHFFFAOYSA-N kojic acid Natural products OC(=O)C(N)CN1C=CC(=O)C(O)=C1 WZNJWVWKTVETCG-UHFFFAOYSA-N 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 229940099563 lactobionic acid Drugs 0.000 description 1
- 229940094522 laponite Drugs 0.000 description 1
- 229920005610 lignin Polymers 0.000 description 1
- 125000005645 linoleyl group Chemical group 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- XCOBTUNSZUJCDH-UHFFFAOYSA-B lithium magnesium sodium silicate Chemical compound [Li+].[Li+].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[Na+].[Na+].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3 XCOBTUNSZUJCDH-UHFFFAOYSA-B 0.000 description 1
- IQPNAANSBPBGFQ-UHFFFAOYSA-N luteolin Chemical compound C=1C(O)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=C(O)C(O)=C1 IQPNAANSBPBGFQ-UHFFFAOYSA-N 0.000 description 1
- 235000009498 luteolin Nutrition 0.000 description 1
- LRDGATPGVJTWLJ-UHFFFAOYSA-N luteolin Natural products OC1=CC(O)=CC(C=2OC3=CC(O)=CC(O)=C3C(=O)C=2)=C1 LRDGATPGVJTWLJ-UHFFFAOYSA-N 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 229940099690 malic acid Drugs 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 229960002510 mandelic acid Drugs 0.000 description 1
- 229940099596 manganese sulfate Drugs 0.000 description 1
- 235000007079 manganese sulphate Nutrition 0.000 description 1
- 239000011702 manganese sulphate Substances 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical compound [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 description 1
- LUEWUZLMQUOBSB-GFVSVBBRSA-N mannan Chemical class O[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@@H](O[C@@H]2[C@H](O[C@@H](O[C@H]3[C@H](O[C@@H](O)[C@@H](O)[C@H]3O)CO)[C@@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O LUEWUZLMQUOBSB-GFVSVBBRSA-N 0.000 description 1
- FYGDTMLNYKFZSV-UHFFFAOYSA-N mannotriose Natural products OC1C(O)C(O)C(CO)OC1OC1C(CO)OC(OC2C(OC(O)C(O)C2O)CO)C(O)C1O FYGDTMLNYKFZSV-UHFFFAOYSA-N 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- XJRBAMWJDBPFIM-UHFFFAOYSA-N methyl vinyl ether Chemical group COC=C XJRBAMWJDBPFIM-UHFFFAOYSA-N 0.000 description 1
- 229920003087 methylethyl cellulose Polymers 0.000 description 1
- HWPKGOGLCKPRLZ-UHFFFAOYSA-M monosodium citrate Chemical compound [Na+].OC(=O)CC(O)(C([O-])=O)CC(O)=O HWPKGOGLCKPRLZ-UHFFFAOYSA-M 0.000 description 1
- 239000002524 monosodium citrate Substances 0.000 description 1
- 235000018342 monosodium citrate Nutrition 0.000 description 1
- 125000001421 myristyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- WZZVUHWLNMNWLW-UHFFFAOYSA-N n-[5-[3-acetamido-5-[3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4-hydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2,4-dihydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide Chemical compound OC1C(NC(=O)C)C(O)OC(CO)C1OC1C(NC(C)=O)C(O)C(OC2C(C(O)C(O)C(CO)O2)NC(C)=O)C(CO)O1 WZZVUHWLNMNWLW-UHFFFAOYSA-N 0.000 description 1
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000001624 naphthyl group Chemical group 0.000 description 1
- 229920005615 natural polymer Polymers 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 229960003966 nicotinamide Drugs 0.000 description 1
- 235000005152 nicotinamide Nutrition 0.000 description 1
- 239000011570 nicotinamide Substances 0.000 description 1
- MGFYIUFZLHCRTH-UHFFFAOYSA-N nitrilotriacetic acid Chemical compound OC(=O)CN(CC(O)=O)CC(O)=O MGFYIUFZLHCRTH-UHFFFAOYSA-N 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 125000001117 oleyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])/C([H])=C([H])\C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 description 1
- 229960003330 pentetic acid Drugs 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 239000008177 pharmaceutical agent Substances 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 150000003009 phosphonic acids Chemical class 0.000 description 1
- 150000003016 phosphoric acids Chemical class 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229950001046 piroctone Drugs 0.000 description 1
- BTSZTGGZJQFALU-UHFFFAOYSA-N piroctone olamine Chemical compound NCCO.CC(C)(C)CC(C)CC1=CC(C)=CC(=O)N1O BTSZTGGZJQFALU-UHFFFAOYSA-N 0.000 description 1
- 239000004854 plant resin Substances 0.000 description 1
- 229920000058 polyacrylate Polymers 0.000 description 1
- 229920001515 polyalkylene glycol Polymers 0.000 description 1
- 229920000157 polyfructose Polymers 0.000 description 1
- 229920000193 polymethacrylate Polymers 0.000 description 1
- 229920005862 polyol Polymers 0.000 description 1
- 150000003077 polyols Chemical class 0.000 description 1
- 229920001289 polyvinyl ether Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- KYKNRZGSIGMXFH-ZVGUSBNCSA-M potassium bitartrate Chemical compound [K+].OC(=O)[C@H](O)[C@@H](O)C([O-])=O KYKNRZGSIGMXFH-ZVGUSBNCSA-M 0.000 description 1
- 239000001508 potassium citrate Substances 0.000 description 1
- 229960002635 potassium citrate Drugs 0.000 description 1
- QEEAPRPFLLJWCF-UHFFFAOYSA-K potassium citrate (anhydrous) Chemical compound [K+].[K+].[K+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O QEEAPRPFLLJWCF-UHFFFAOYSA-K 0.000 description 1
- 235000011082 potassium citrates Nutrition 0.000 description 1
- 235000011118 potassium hydroxide Nutrition 0.000 description 1
- 159000000001 potassium salts Chemical class 0.000 description 1
- 239000001472 potassium tartrate Substances 0.000 description 1
- 229940111695 potassium tartrate Drugs 0.000 description 1
- 235000011005 potassium tartrates Nutrition 0.000 description 1
- 150000003138 primary alcohols Chemical class 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 235000010409 propane-1,2-diol alginate Nutrition 0.000 description 1
- 239000000770 propane-1,2-diol alginate Substances 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 229940107700 pyruvic acid Drugs 0.000 description 1
- 150000004717 pyruvic acids Chemical class 0.000 description 1
- 239000002516 radical scavenger Substances 0.000 description 1
- 239000013557 residual solvent Substances 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000012260 resinous material Substances 0.000 description 1
- 229930002330 retinoic acid Natural products 0.000 description 1
- 229960003471 retinol Drugs 0.000 description 1
- 235000020944 retinol Nutrition 0.000 description 1
- 239000011607 retinol Substances 0.000 description 1
- 229960000342 retinol acetate Drugs 0.000 description 1
- QGNJRVVDBSJHIZ-QHLGVNSISA-N retinyl acetate Chemical compound CC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C QGNJRVVDBSJHIZ-QHLGVNSISA-N 0.000 description 1
- 235000019173 retinyl acetate Nutrition 0.000 description 1
- 239000011770 retinyl acetate Substances 0.000 description 1
- 229940108325 retinyl palmitate Drugs 0.000 description 1
- 235000019172 retinyl palmitate Nutrition 0.000 description 1
- 239000011769 retinyl palmitate Substances 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 210000002374 sebum Anatomy 0.000 description 1
- 150000003333 secondary alcohols Chemical class 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- HELHAJAZNSDZJO-OLXYHTOASA-L sodium L-tartrate Chemical compound [Na+].[Na+].[O-]C(=O)[C@H](O)[C@@H](O)C([O-])=O HELHAJAZNSDZJO-OLXYHTOASA-L 0.000 description 1
- 229960001790 sodium citrate Drugs 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 239000001433 sodium tartrate Substances 0.000 description 1
- 229960002167 sodium tartrate Drugs 0.000 description 1
- 235000011004 sodium tartrates Nutrition 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 229950004959 sorbitan oleate Drugs 0.000 description 1
- 239000012798 spherical particle Substances 0.000 description 1
- 125000004079 stearyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 150000003450 sulfenic acids Chemical class 0.000 description 1
- 150000003460 sulfonic acids Chemical class 0.000 description 1
- 230000000475 sunscreen effect Effects 0.000 description 1
- 239000000516 sunscreening agent Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 210000001179 synovial fluid Anatomy 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 229960001727 tretinoin Drugs 0.000 description 1
- ILJSQTXMGCGYMG-UHFFFAOYSA-N triacetic acid Chemical compound CC(=O)CC(=O)CC(O)=O ILJSQTXMGCGYMG-UHFFFAOYSA-N 0.000 description 1
- ZIBGPFATKBEMQZ-UHFFFAOYSA-N triethylene glycol Chemical class OCCOCCOCCO ZIBGPFATKBEMQZ-UHFFFAOYSA-N 0.000 description 1
- 235000001019 trigonella foenum-graecum Nutrition 0.000 description 1
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 1
- 150000004043 trisaccharides Chemical group 0.000 description 1
- 229910052721 tungsten Inorganic materials 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 210000003954 umbilical cord Anatomy 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 210000004127 vitreous body Anatomy 0.000 description 1
- 239000007762 w/o emulsion Substances 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
- 229960003487 xylose Drugs 0.000 description 1
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 1
- 229960001763 zinc sulfate Drugs 0.000 description 1
- 229910000368 zinc sulfate Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/733—Alginic acid; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0212—Face masks
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/23—Sulfur; Selenium; Tellurium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/731—Cellulose; Quaternized cellulose derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A61K8/8141—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
- A61K8/8152—Homopolymers or copolymers of esters, e.g. (meth)acrylic acid esters; Compositions of derivatives of such polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/88—Two- or multipart kits
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/88—Two- or multipart kits
- A61K2800/882—Mixing prior to application
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Immunology (AREA)
- Emergency Medicine (AREA)
- Cosmetics (AREA)
Abstract
A kit, comprising: (1) a first composition comprising at least one water-insoluble polyvalent metal salt and at least one water-soluble polyhydroxy polymer, and (2) a second composition comprising at least one aqueous phase, and a) optionally, at least one water-soluble polyvalent metal ion sequestering agent, and b) at least one water-soluble gelling agent that can form a gel with polyvalent metal ions. The kit can be used for caring for keratin materials, in particular the skin, for managing skin wounds, for preventing post-operative adhesion formation or for filling or repairing osteochondral defects.
Description
Technical Field
The present invention relates to an alginic system, in particular to an alginic kit for skin care. The invention also relates to the use thereof, in particular as a mask for caring for keratin materials, in particular the skin.
Background
The ultimate goal in the cosmetic field has always been to provide consumers with highly effective products with skin benefits such as hydration, moisturization, whitening, cleansing, and the like.
Among all the compositions used for caring for keratin materials, in particular the skin, facial masks are known to have a high penetration efficacy on keratin materials. Thus, a two-digit market for facial mask type cosmetics is seen in china.
There are generally four types of facial masks, i.e., a cream-type, peel-off, gel-type, and wet-towel type facial mask. Among them, the cream-type and peel-off-type masks are mainly used for cleansing keratin materials, while the gel-type and wet-towel-type masks are more commonly used for skin care. It is known that a gel type mask has good adhesion to the skin and can provide good freshness sensation, but may not sufficiently deliver moisturizing or hydrating effects to the skin, while a wet tissue type mask excels in delivering moisturizing and hydrating effects but withdraws the effects if applied for a long time. Furthermore, adhesion to skin may not be as good as a gel-type mask.
Meanwhile, for a mask, particularly a facial mask of a paper towel type, it is desired that the mask applied on the face is soft to bring a better tactile sensation and a better skin fitting degree.
Based on the above, there is a need for a new mask that combines two or more of the advantages exhibited by known mask types, but does not have one or more of the problems associated therewith.
Object of the Invention
Accordingly, in one aspect, there is a need to provide a mask that is capable of undergoing a texture transition, such as from a paper towel to a gel, to bring about a pleasant consumer experience.
In another aspect, there is a need to provide a mask that has at least comparable or even greater moisture or active delivery capacity than observed with wet-wipe type masks.
In another aspect, there is a need to provide a mask which has good adhesion to the skin and can provide freshness as a gel type mask.
In another aspect, there is a need to provide a mask which can deliver a moisturizing effect or active to a keratin material for a long period of time without withdrawing the effect, thereby exhibiting further improved, for example, hydration effect as compared to a wet-wipe type mask.
In another aspect, there is a need to provide a mask that is significantly effective in improving fine lines.
In another aspect, it is necessary to provide a mask that combines all of the benefits described in the above aspects.
In another aspect, the inventors have discovered that the concepts or principles of the present invention are applicable not only to the cosmetic field, but also to other fields, such as the medical field, and thus the facial masks of the above aspects can be broadened to kits (kits) that also exhibit the benefits described herein with respect to these facial masks.
DISCLOSURE OF THE INVENTION
The present inventors have found that one or more of the above requirements can be met by a particular combination comprising: 1) a first composition comprising at least one water insoluble polyvalent metal salt as an ion donor for the polyvalent metal, and at least one water soluble polyhydric polymer; and 2) a second composition comprising at least one aqueous phase, and a) optionally, at least one water-soluble polyvalent metal ion sequestering agent, and b) at least one water-soluble gelling agent capable of forming a gel with polyvalent metal ions.
One subject of the present invention is therefore to provide a kit comprising a first composition and a second composition placed separately from each other.
Another subject of the invention is a mask pack 1 comprising: 1) a first composition comprising at least one water-insoluble polyvalent metal salt, at least one hydroxyl-rich fiber, and at least one water-soluble polyhydroxy polymer, and 2) a fourth composition comprising at least one aqueous phase, and b) at least one water-soluble gelling agent capable of forming a gel with polyvalent metal ions; wherein the first composition and the fourth composition are disposed separately from each other.
Another subject of the invention is the use of a second composition as a juice (juice) or part of a juice of a mask product, wherein said mask product comprises, separately from the second composition, a fabric (or a tissue) comprising at least one water-insoluble polyvalent metal salt according to the invention.
Another subject of the invention is the use of a kit according to the invention for the care of keratin materials, in particular the skin. Such use may be represented by a method for treating keratin materials, in particular the skin, comprising the steps of compounding the first and second compositions of the kit in a predetermined weight ratio, and then applying the mixture thus obtained to the keratin materials.
Another subject of the invention is the use of a kit according to the invention for managing skin wounds, for preventing post-operative adhesion formation or for filling or repairing osteochondral defects or the like. Such use may be represented by a method for managing skin wounds, preventing post-operative adhesion formation or filling or repairing osteochondral defects comprising the steps of compounding the first and second compositions of the kit in a predetermined weight ratio and then applying to a site in need of the mixture thus obtained.
Other features and advantages of the present invention will become more apparent upon reading the following specification and examples.
Detailed Description
Other than in the operating examples, or where otherwise indicated, all numbers expressing quantities of ingredients and/or reaction conditions are to be understood as being modified in all instances by the term "about", meaning within 10% of the number indicated (e.g., "about 10%" means 9% to 11%, and about "2%" means 1.8% to 2.2%).
The articles "a" and "an" as used herein mean one or more when applied to any feature in embodiments of the present invention described in the specification and claims. The use of "a" and "an" does not limit the meaning to a single feature unless such a limit is specifically indicated. The article "the" preceding singular or plural nouns or noun phrases denotes a particular specified feature or particular specified features and may have a singular or plural connotation depending upon the context in which it is used. The adjective "any" means one, some, or all, with no distinction being made between amounts.
The term "comprising" (and grammatical variants thereof) as used herein is used in an inclusive sense of "having" or "including," and not in an exclusive sense of "consisting only of …. Nevertheless, the skilled person will undoubtedly recognize that, for an embodiment that can be implemented in "comprising" form, "the form" consisting essentially of … and "consisting of …" is naturally a modification of this embodiment and is also within the scope of the invention.
All percentages and ratios are by weight unless otherwise indicated. All percentages are based on the total weight of the composition, unless otherwise indicated. The level of all components or compositions refers to the active level of that component or composition and excludes impurities, such as residual solvents or by-products, that may be present in commercially available sources.
Preferably, the "keratin material" according to the invention is the skin. By "skin" is meant the whole body of the skin. Still preferably, the keratin material is the face or neck, especially the face.
By "topical application" is meant that the composition is applied or spread onto at least one area of the surface of the keratin material, such as the skin.
By "rinse-off" is meant a composition that is removed from the skin by a rinse-off composition, such as water, after a predetermined time has been applied to the skin.
"alkali metal" means an element in group IA of the periodic Table, such as sodium, potassium, lithium or combinations thereof, preferably sodium, potassium or combinations thereof.
The term "water-soluble or water-dispersible" refers to a compound which, when introduced into water at 25 ℃ in a concentration by mass equal to 1%, makes it possible to obtain a macroscopically homogeneous and transparent solution, i.e. a solution having a maximum light transmission value of at least 60%, preferably at least 70%, through a 1 cm-thick sample at a wavelength equal to 500 nm.
In this application, unless explicitly mentioned otherwise, the contents, parts and percentages are by weight.
According to the invention, the kit comprises a first composition and a second composition.
First composition
First, a first composition according to the present invention comprises at least one water-insoluble polyvalent metal salt and at least one water-soluble polyhydroxypolymer.
Water-insoluble polyvalent metal salt
The term "water-insoluble" means that the salt is insoluble in water, e.g. has a solubility of less than 0.01g/100g of water, or only slightly soluble in water, e.g. has a solubility of less than 0.5g/100g of water, and does not disintegrate into the bulk state when immersed in water.
In particular, the at least one water-insoluble polyvalent metal salt may be present in the form of a powder, granules, fibres or in the bulk state (bulk state).
For the purposes of the present invention, the term "microparticles" when used with respect to a water-insoluble polyvalent metal salt means that the salt is in particulate form.
In particular, the water-insoluble polyvalent metal salt may be formed from an acid anion and a polyvalent metal cation, especially calcium, strontium, zinc, copper, manganese, aluminum or mixtures thereof. The metal which can be used is preferably calcium, copper or a mixture thereof, more preferably calcium.
The acid providing the acid anion according to the present invention may be any known acid useful for cosmetics as long as the salt formed from the acid and the polyvalent metal is water-insoluble or sparingly soluble. Typical acids which may be used include various inorganic acids, such as sulfuric acid, carbonic acid, phosphoric acid, meta-aluminic acid, silicic acid, and various organic acids, especially highly saturated or unsaturated fatty acids, especially those having 18 or more carbon atoms, such as stearic acid and oleic acid, or polycarboxylic acids, especially such as alginic acid, oxalic acid, as long as the salts formed are water-insoluble or sparingly soluble.
More specifically, the at least one water-insoluble polyvalent metal salt may be a sulfate or alginate, preferably selected from calcium sulfate/alginate, strontium sulfate/alginate, zinc sulfate/alginate, copper sulfate/alginate, manganese sulfate/alginate or mixtures thereof, preferably calcium sulfate/alginate or copper sulfate/copper alginate, in particular calcium sulfate/alginate.
The term "alginate" refers in particular to salts of alginic acid. Alginic acid, a natural substance obtained from brown algae or from certain bacteria, is composed of two uronic acids linked together via a 1, 4-glycosidic bond: polyuronic acid consisting of beta-D-mannuronic acid (M) and alpha-L-glucuronic acid (G).
Water-insoluble alginates in which the main cation is calcium are present in particular in Phaeophyceae (A)Phaeophyceae) In the fronds and stems of the seaweed of (a), an example of the seaweed is Fucus vesiculosus (Fucus vesiculosus)Fucus vesiculosus) Spirulina, spirulina (2)Fucus spiralis) Ascophyllum nodosum (Ascophyllum nodosum.)Ascophyllum nodosum) Giant kelpMacrocystis pyrifera) Winged algae (c)Alaria esculenta)、Eclonia maximaGiant kelp (A) and (B)Lessonia nigrescens)、Lessonia trabeculataSea tangle (A)Laminaria japonica) Antarctic Pleurotus ostreatus (A. clarkii)Durvillea antarctica) Northern sea tangle (Laminaria hyperborea) Brown algae of longstrand (Laminaria longicruris) Laminaria digitata (Laminaria digitata)Laminaria digitata) Sugar-coated kelp (Tangle)Laminaria saccharina) Kelps and kelps (1)Laminaria cloustoni) AndSaragassum sp.。
suitable water insoluble alginates have a weight average molecular weight of about 20,000 daltons to about 500,000 daltons. As in Martinsen et al, "comprehensive of Differencen Methods for Determination of Molecular Weights and Molecular Weight Distribution of Alginates" (Carbohydr. Polymer., 15, 171-Bukurad 193, 1991), the intrinsic viscosity is first determined and the Weight average Molecular Weight is then calculated using the Mark-Houwink Sakurad equation.
Water-soluble polyhydroxy polymers
The term "polyhydroxy polymer" refers to hydroxyl-containing nonionic polysaccharides.
The present inventors have surprisingly found that polymers rich in hydroxyl groups can soften fibers, especially when the fibers are also rich in hydroxyl groups. Herein, hydroxyl-rich fibers refer to fibers having at least 2 hydroxyl groups, preferably at least 3 hydroxyl groups per repeat unit of the polymer of the fiber and having at least one hydroxyl-containing side chain wherein less than 60%, preferably less than 30% or preferably less than 15% of the hydroxyl groups in the side chain are substituted.
Useful water-soluble polyhydroxy polymers include polyhydroxy carboxylic acids, acid esters; a polyhydroxycellulose; and the like.
Some celluloses are known to be useful in promoting gelling behavior. Accordingly, polyhydroxycellulose is preferably usable.
In particular, nonionic polyhydroxycellulose ethers are particularly preferred, among which hydroxyalkyl celluloses, such as hydroxymethylcellulose, Hydroxyethylcellulose (HEC) and Hydroxypropylcellulose (HPC), may be mentioned; and mixed hydroxyalkyl alkylcelluloses such as hydroxypropylmethylcellulose, hydroxyethylmethylcellulose, hydroxyethylethylcellulose and hydroxybutylmethylcellulose.
According to one embodiment, the first composition of the invention may comprise said at least one water-soluble polyhydroxypolymer in a content ranging from 0.001% to 1% by weight, in particular from 0.01% to 0.1% by weight, for example from 0.01% to 0.06%, relative to the total weight of the first composition.
Super absorbent material (Superabsorbent material)
According to one embodiment of the invention, the first composition may comprise at least one superabsorbent material.
In particular, the at least one superabsorbent material may be present in the form of a powder, granules, fibres or in the bulk state (bulk state).
Superabsorbent materials advantageously exhibit an extremely high capacity to absorb liquids, in particular water. In particular, it may exhibit a capacity to absorb 15 times, or even 20 to 50 times, for example about 25 to 30 times, its own weight of water.
The liquid absorption capacity of a superabsorbent material can be determined by carrying out the following method.
Weighing (M) a sample of powder, fibres or superabsorbent material in bulk state or arranged as a film or sheet in dry stateD). For example, a square nonwoven web having sides of about 1 centimeter (cm) may be used. In the context of the present process, the superabsorbent material is obtained in the "dry" state by treatment in a drying oven at about 50 ℃ for about 4 hours (h).
Water (or any other liquid to be absorbed by the material) is brought into contact with the material. This can be done by immersing the material in a liquid or by pouring a liquid onto the material. For example, the material may be soaked for a duration of about 1 minute (min).
Excess water (or liquid) is used, for example, to completely saturate the material. Excess water (or liquid) is then removed, for example by drip-drying for about 2 minutes, and the liquid-saturated material is weighed (M)L)。
The difference Δ between the weight of the material when saturated with liquid and the weight of the material when dry represents the amount of liquid that the material has absorbed, and this weight is compared to the dry weight of the material. The resulting value C indicates the capacity of the superabsorbent material to absorb liquid, for example expressed in grams of liquid absorbed per gram of dry material:
the superabsorbent material may be selected from cellulose derivatives, alginates (excluding water insoluble alginates and alkali metal alginic acid compounds described herein as water soluble gelling agents) and derivatives thereof, particularly derivatives such as propylene glycol alginate or salts thereof, derivatives of polyacrylic or polymethacrylic acid, derivatives of poly (meth) acrylamide, derivatives of polyvinylpyrrolidone, derivatives of polyvinyl ether, mixtures thereof, and the like.
In particular, the superabsorbent material may be selected from chemically modified cellulose derivatives. For example, it may be selected from the group consisting of carboxymethyl cellulose, sodium carboxymethyl cellulose, carboxymethyl hydroxyethyl cellulose, carboxyethyl cellulose, hydroxyethyl ethyl cellulose, hydroxypropyl methyl cellulose, sodium methyl cellulose, microcrystalline cellulose, sodium cellulose sulfate, and mixtures thereof.
It may also be selected from alkyl celluloses. These polymers are obtained by grafting alkyl residues onto one or more hydroxyl groups of the cellulose polymer to form hydroxyalkyl derivatives. These alkyl residues may be selected from the following groups: stearyl, isostearyl, lauryl, myristyl, cetyl, isocetyl, cocoyl, palmityl, oleyl, linoleyl (linonyl), ricinoleyl (ricinoyl), behenyl and mixtures thereof. These hydroxyalkyl cellulose derivatives may also be subjected to chemical modifications, for example using carboxylic acid residues (carboxylic acid residues).
The superabsorbent material may also be selected from natural polymer derivatives such as gellan gum and glucomannan and galactomannan polysaccharides extracted from seeds, plant fibers, fruits, seaweed, starch, plant resins or even microbial sources. For example, it may be selected from agar gum (agar gum), guar gum, tragacanth gum, carrageenan, konjac gum, locust bean gum, gellan gum, xanthan gum, and mixtures thereof.
In particular, the first composition of the invention may comprise said at least one superabsorbent material in a content or even in a residual amount (the rest) of from 0% to 80% by weight, in particular from 50% to 80% by weight, relative to the total weight of the first composition.
According to one embodiment of the invention, in particular for facial mask use, the first composition further comprises additional fibers other than the fibers formed by the at least one water-insoluble multivalent metal salt, wherein the at least one water-insoluble multivalent metal salt and the at least one water-soluble polyhydroxy polymer are loaded onto the additional fibers.
For example, according to embodiment 1, the water-insoluble polyvalent metal salt may be present in the form of fibers. The fibers of the at least one water insoluble multivalent metal salt may then be formed into a water insoluble substrate, either alone or with one or more other fibers. A water-soluble polyhydroxy polymer is loaded onto the substrate.
Alternatively, according to embodiment 2, the water-insoluble polyvalent metal salt and the water-soluble polyhydric polymer may be each uniformly distributed in the water-insoluble substrate.
Water insoluble substrate
For the purposes of the present invention, the term "water-insoluble" means that the substrate is insoluble in water and does not disintegrate upon immersion in water.
Embodiment 1:
generally, in this embodiment 1, the substrate may be a woven fabric or a nonwoven fabric made of the fibers of the at least one water-insoluble polyvalent metal salt (hereinafter also referred to as water-insoluble polyvalent metal salt fibers) together with at least one other fiber selected from natural fibers such as cotton, pulp, bamboo and cellulose fibers, semi-natural fibers such as viscose rayon fibers, synthetic fibers such as polyester fibers, polyethylene terephthalate fibers, polyethylene fibers and polypropylene fibers. Two or more selected from other fibers may be used in combination.
The present inventors have surprisingly found that hydroxyl-rich fibers can be easily softened with water-soluble polyhydroxyl polymers. Therefore, fibers rich in hydroxyl groups are preferably used according to the invention. Such fibers may be regenerated cellulose or cotton fibers. Examples of hydroxyl-rich fibers include Viscose (Viscose), Modal (Modal), Lyocell (Lyocell), Cupro (Cupro), Cotton (Cotton), and the like.
The substrate can be made in a wide variety of shapes and forms, such as flat pads, thick pads, thin sheets of irregular thickness, depending on the desired use and characteristics of the kit. By way of example only, in the case of a mask, the substrate is typically designed to fit the area of skin to which topical application is desired. To this end, the substrate is designed to correspond to the shape of the face, avoiding the eyes, nostrils and mouth area as needed when applying the mask to the face. Non-limiting examples of substrates that can be used in the present invention are described in, for example, patent application WO 02/062132 or EP 2489286 a.
According to embodiment 1, the water-insoluble polyvalent metal salt is preferably formed from organic acids, especially highly saturated or unsaturated fatty acids, especially those having 18 or more carbon atoms, such as stearic acid and oleic acid, or polycarboxylic acids, such as alginic acid, oxalic acid, among others.
In particular, the water insoluble substrate or fabric may comprise water insoluble polyvalent metal salt fibers, especially calcium alginate fibers, in an amount of from 10 to 80% by weight, especially from 10 to 40% by weight, relative to the total weight of the water insoluble substrate or fabric. Accordingly, the water insoluble substrate or fabric may comprise the at least one further fiber in an amount of from 10 to 80 wt. -%, in particular from 50 to 80 wt. -%, relative to the total weight of the water insoluble substrate or fabric.
More particularly, suitable nonwoven fabrics comprising calcium alginate fibers are commercially available from Sanjiang under the name M762R-40 CN.
Embodiment 2:
alternatively, according to embodiment 2, the substrate may comprise a woven or non-woven fabric consisting essentially of fibers selected from natural fibers, such as cotton, pulp, bamboo, and cellulose fibers; semi-natural fibers such as viscose rayon fibers; synthetic fibers such as at least one of polyester fibers, polyethylene terephthalate fibers, polyethylene fibers, and polypropylene fibers. For such substrates, the at least one water-insoluble multivalent metal salt is distributed in the substrate as homogeneously as possible.
Accordingly, water-insoluble polyvalent metal salts are prepared as aqueous dispersions, for example for water-insoluble calcium salts. The dispersion is then applied to a substrate, for example by coating, spraying or the like, so that the calcium salt is uniformly distributed in the substrate in an amount sufficient to form a gel with the alginate on the substrate. The wet substrate loaded with the aqueous salt (aquouous salt) is subsequently dried. The method of drying the tissue is not particularly limited. For industrial applications, the wet substrate is dried in an economically efficient manner.
According to another embodiment, the water-insoluble polyvalent metal salt, such as a calcium salt, in solid form, for example as a water-insoluble salt, is crushed into a powder or granules, for example by milling, grinding or the like. The powder or particles are then applied uniformly to the substrate. The diameter of the powder or particles is not particularly limited as long as the water-insoluble multivalent metal salt can be uniformly distributed in the substrate in an amount sufficient to form a gel with the alginate on the substrate.
According to embodiment 2, the water-insoluble polyvalent metal salt is preferably formed from an inorganic acid, for example, one selected from the group consisting of sulfonic acid, carbonic acid, phosphoric acid, meta-aluminate, silicic acid, preferably sulfonic acid.
According to embodiment 2, the water-insoluble substrate or fabric may comprise water-insoluble multivalent metal salts, especially calcium salts, in an amount of from 0.01 to 5 wt. -%, preferably from 0.02 to 1 wt. -% or preferably from 0.04 to 0.5 wt. -%, relative to the total weight of the water-insoluble substrate or fabric.
Method for bonding a polyhydroxy polymer to a substrate
To provide a softened substrate, a water-soluble polyhydroxy polymer is preferably combined with a water-insoluble substrate. The method of combining the water-soluble polyhydroxy polymer with the water-insoluble substrate is not particularly limited as long as the water-soluble polyhydroxy polymer can be uniformly distributed in the substrate in an amount sufficient to soften the substrate to a desired degree.
According to one embodiment, the water-soluble polyhydroxy polymer is prepared as an aqueous solution. The water-soluble polyhydroxy polymer is then loaded onto a substrate, such as a facial mask towel.
According to another embodiment, the water-soluble polyhydroxy polymer is prepared as a suspension or paste, for example, by suspending or mixing the water-soluble polyhydroxy polymer in or with a non-aqueous medium to form a suspension or paste thereof. The suspension or paste is then applied to a substrate, for example by coating, spraying or the like, so that the water-soluble polyhydroxy polymer is uniformly distributed in the substrate in an amount sufficient to form a gel with the alginate on the substrate.
In the case of application of the water-soluble polyhydroxypolymer using an aqueous solution, suspension or paste, the wet substrate loaded with an aqueous salt (aquous salt) is subsequently dried. The method of drying the tissue is not particularly limited. For industrial applications, the wet substrate is dried in an economically efficient manner.
According to yet another embodiment, the water-soluble polyhydroxy polymer in solid form is crushed into a powder or granules, for example by milling, grinding or the like. The powder or particles are then applied uniformly to the substrate. The diameter of the powder or particles is not particularly limited as long as the water-soluble polyhydroxy polymer can be uniformly distributed in the substrate in an amount sufficient to soften the substrate.
According to the present invention, the water-insoluble substrate or fabric may comprise a water-soluble polyhydroxy polymer, such as HEC or HPC, in an amount of from 0.001 to 1 wt. -%, in particular from 0.01 to 0.1 wt. -%, for example from 0.01 to 0.06%, relative to the total weight of the water-insoluble substrate or fabric.
The kit according to the present invention comprises a second composition separate and apart from the first composition (e.g. water insoluble substrate). The second composition is impregnated, coated or otherwise contacted with the first composition as desired to transform the texture of the first composition, for example from a paper towel to a gel.
Preferably, the weight ratio of the first composition (e.g. water insoluble substrate or fabric) to the second composition is from 1:3 to 1:20, preferably from 1:8 to 1:15, in order for sufficient texture transformation to occur.
Second composition
The second composition of the invention comprises at least a) optionally, at least one water-soluble polyvalent metal ion sequestering agent and b) at least one water-soluble gelling agent that forms a gel with polyvalent metal ions.
According to the present invention, when the first composition is mixed with the second composition, the water-insoluble polyvalent metal ion donor reacts with the salt in the solution and releases the polyvalent metal ion. When the second composition does not comprise component a), i.e. the at least one water-soluble multivalent metal ion chelating agent, the multivalent metal ions released into the solution react directly with component b), i.e. the at least one water-soluble gelling agent. When the second composition comprises component a), the polyvalent metal ions released into the solution will be largely captured by the water-soluble chelating agent. A few free polyvalent metal ions react in solution with the water-soluble gelling agent and begin to form a gel on the surface of the tissue. As the concentration of free polyvalent metal ions decreases over time, the chelated polyvalent metal ions will be gradually released and then form a gel on the surface of the tissue. After a short time, a shift in the tissue texture and a homogeneous gel on the tissue surface was observed.
Polyvalent metal ion chelating agent
The second composition according to the present invention comprises optional component a), i.e. at least one water-soluble polyvalent metal ion chelating agent, to promote the texture transformation, in particular at least to enhance the moisture or active delivery capacity. The water-soluble polyvalent metal ion chelator is water-soluble.
According to the invention, the water-insoluble polyvalent metal ion donor releases more or less polyvalent metal ions into solution when the first composition is mixed with the second composition comprising component a). Both the chelating agent for the polyvalent metal ion and the water-soluble gelling agent are capable of binding the polyvalent metal ion.
Surprisingly, the specific chelating agent according to the invention competes with the gelling agent in competition for binding to the polyvalent metal ion, so that the released polyvalent metal ion is largely captured by the water-soluble chelating agent. There is still a small number of free polyvalent metal ions that react in solution with the water-soluble gelling agent and begin to form a gel on the surface of the tissue. As the concentration of free polyvalent metal ions decreases over time, the chelated polyvalent metal ions will be gradually released and then form a gel on the surface of the tissue. That is, the specific chelating agent according to the present invention acts as a reservoir (reservoir) for polyvalent metal ions that form a gel on the surface of the tissue.
Useful polyvalent metal ion chelating agents according to the present invention include aminocarboxylic acids such as ethylenediaminetetraacetic acid (EDTA), aminotriacetic acid, diethylenetriaminepentaacetic acid, particularly alkali metal salts thereof such as N, N-bis (carboxymethyl) glutamic acid, tetrasodium EDTA, tetrasodium salt of N, N-bis (carboxymethyl) glutamic acid (glutamic diacetic acid, GLDA); hydroxycarboxylic acids, such as citric acid, tartaric acid, glucuronic acid, succinic acid, ethylenediamine disuccinic acid (EDDS), especially alkali metal salts thereof; hydroxyaminocarboxylic acids, such as hydroxyethylethylenediaminetriacetic acid (HEDTA), Dihydroxyethylglycine (DEG), in particular their alkali metal salts; polyphosphonic acids, especially alkali metal salts thereof; other phosphorus-containing organic acids, such as phytic acid, in particular alkali metal salts thereof, e.g. sodium phytate, potassium phytate; polycarboxylic acids, such as polyacrylic acids, polymethacrylic acids, in particular their alkali metal salts.
In one embodiment, the at least one water-soluble polyvalent metal ion chelating agent is an alkali metal hydroxypolycarboxylate, represented by an alkane containing 1 to 4 carbon atoms, preferably 2 or 3 carbon atoms, substituted by 1,2 or 3 hydroxyl groups (-OH), preferably by one (1) hydroxyl group, and further substituted by 2,3, 4 or 5 carboxylic acid/carboxylate groups (-COOM), preferably by 2 or 3 carboxylic acid/carboxylate groups (-COOM), wherein a plurality of groups M independently represent H or an alkali metal, with the proviso that at least one group M represents an alkali metal, such as Na, K or Li, preferably all groups M represent an alkali metal, such as Na, K or Li, preferably Na. More specifically, the at least one alkali metal hydroxypolycarboxylate may be selected from sodium tartrate, sodium citrate, potassium tartrate, potassium citrate and hydrates thereof, preferably sodium citrate, in particular trisodium citrate. Sodium citrate is used herein to denote monosodium citrate, disodium citrate and trisodium citrate, other alkali metal hydroxypolycarboxylates being understood in a similar manner.
The alkali metals mentioned above are particularly preferably sodium or potassium, in particular sodium. Accordingly, preferred chelating agents may include sodium citrate, tetrasodium EDTA, tetrasodium GLDA, trisodium EDDS, sodium phytate, or mixtures thereof.
In particular, the second composition of the invention may comprise the at least one water-soluble multivalent metal ion chelating agent in a content of 0.1 to 1 wt. -%, in particular of 0.2 to 0.4 wt. -%, relative to the total weight of the second composition.
Water-soluble gelling agent
The second composition according to the invention comprises at least one water-soluble gelling agent which can form a gel with the polyvalent metal ion to induce a texture transformation.
In the present application, the term "water-soluble gelling agent" particularly refers to a gelling agent that can form a gel with the polyvalent metal ions from the first composition.
According to the invention, the water-insoluble polyvalent metal ion donor releases more or less polyvalent metal ions into the solution when the first composition is mixed with the second composition.
The gelling agent, according to the principles of the present invention, can thus be any gelling agent that can form a gel with the polyvalent metal ion. Examples of gelling agents may include gelatin, pectin, gellan gum, carrageenan, agar, alginic acid compounds, particularly alkali metal salts of alginic acid, such as sodium alginate, and mixtures thereof. When the second composition comprises component a), i.e. a chelating agent, the gelling agent and the chelating agent are specifically selected, wherein the gelling agent has a lower binding capacity to the polyvalent metal ion than the chelating agent to the polyvalent metal ion, such that the gelling agent does not bind to free polyvalent metal ions released directly from the first composition, but to polyvalent metal ions subsequently released from the reservoir (reservoir), i.e. chelated polyvalent metal ions. Accordingly, a gel may be formed on the surface of the first composition.
Pectin is a linear polymer of alpha-D-galacturonic acid (at least 65%) linked in the 1 and 4 positions to a proportion of carboxylic acid groups esterified with methanol groups. About 20% of the sugars constituting the pectin molecule are neutral sugars (L-rhamnose, D-glucose, D-galactose, L-arabinose, D-xylose). L-rhamnose residues are found in all pectins, incorporated into the backbone at positions 1, 2.
The uronic acid molecule carries a carboxyl function. When they are COO-In form, this functionality confers the pectin the ability to exchange ions. Divalent ions (particularly calcium) have the ability to form an ionic bridge between the two carboxyl groups of two different pectin molecules.
In the natural state, a certain proportion of the carboxyl groups are esterified with methanol groups. The natural degree of esterification of pectin can be between 70% (apple, lemon) and 10% (strawberry), depending on the source used.Hydrolysis of-COOCH using pectins having a high degree of esterification3And (c) a group to obtain a weakly esterified pectin. Depending on the proportion of methylated or unmethylated monomers, the chain is therefore more or less acidic. HM (high methoxyl) pectin is thus defined as having a degree of esterification of more than 50% and LM (low methoxyl) pectin is defined as having a degree of esterification of less than 50%.
In the case of amidated pectins, -OCH3radical-NH2And (4) substituting the group.
Pectin is sold in particular by the company Cargill under the name Uninectine ™, CP-Kelco under the name Genu and Danisco under the name Grinsted Pectin.
Carrageenans are anionic polysaccharides that constitute the cell walls of various red algae (Rhodophyceae) belonging to the families Gigartinaae (Gigartinaae), Sargassaceae (Hypneaceae), Furcellareae (Furcellariaceae) and Polyideaceae (Polyideaceae). They are usually obtained by hot water extraction from natural strains of the algae. These linear polymers formed from disaccharide units consist of two D-galactopyranose units alternately linked by α (1,3) and β (1,4) bonds. They are highly sulfated polysaccharides (20-50%) and the alpha-D-galactopyranosyl residues can be in the 3, 6-anhydro form. Depending on the number and position of sulfate groups on the repeating disaccharide of the molecule, several types of carrageenans are distinguished, namely: kappa-carrageenan with one sulfate group, iota-carrageenan with two sulfate groups and lambda-carrageenan with three sulfate groups.
Carrageenan consists essentially of potassium, sodium, magnesium, triethanolamine and/or calcium salts of polysaccharide sulfates.
Carrageenan is in particular Solagum from SEPPIC®As a name, Carragel by Gelymar®、Carralact®And Carrasol®Named, Satiagel and Satiaglum ™ by Cargill, and Genulacta by CP-Kelco®、Genugel®And Genuvisco®Sold under the name of Vietnam.
Agar is a galactose polysaccharide contained in the cell walls of some of the red algae (rhodophyceae) of these species. They are formed of polymer groups whose basic main chains are β (1,3) D-galactopyranose and α (1,4) L3-6 anhydrogalactan chains, these units being regularly and alternately repeated. Differences within the agar family are attributed to the presence or absence of solvated methyl or carboxyethyl groups. These hybrid structures are usually present in variable percentages, depending on the species of algae and the harvest season.
The agar is in the range of 40000 to 300000 g.mol-1A mixture of high molecular weight polysaccharides (agarose and agar). It is obtained by preparing an algae extract, usually by autoclaving, and by treating these liquids containing about 2% agar to extract the agar.
Agar is, for example, known by the B & V Agar products group as Gold Agar, by the Hispanagar company as Agar and Grand Agar, and by the Setexam company as Agar-Agar, QSA (Quick club Agar) and Puragar.
Gellan gum is an anionic linear heteropolyglycoside based on oligoglycoside (oligoside) units (tetraglycosides) consisting of 4 sugars. D-glucose, L-rhamnose and D-glucuronic acid in a ratio of 2:1:1 are present in gellan gum as monomeric units.
It is sold, for example, by CP Kelco under the name kellogel CG LA.
In one embodiment of the invention, the gelling agent is preferably selected from alkali metal alginic acid compounds. Particularly preferred gelling agents are alginates, such as sodium alginate or potassium alginate, especially sodium alginate.
According to one embodiment, the at least one water-soluble gelling agent is present in the second composition at 0.1% to 0.5% by weight, preferably at 0.1% to 0.3% by weight, relative to the total weight of the second composition.
According to the invention, the amounts of chelating agent and gelling agent are selected such that the molar ratio of the fraction released by the chelating agent that can be chelated with the multivalent cations to the fraction released by the gelling agent that can form a gel with the multivalent cations is from about 10:1 to about 1:1, preferably from about 5:1 to about 2: 1.
Alkali metal alginic acid compound
The term "alkali metal alginic acid compound" especially refers to alkali metal alginates (alginates) or alkali metal salts of alginic acid derivatives. The alkali metal alginic acid compound is water soluble.
Alginic acid, a natural substance obtained from brown algae or from certain bacteria, is composed of two uronic acids linked together via a 1, 4-glycosidic bond: polyuronic acid consisting of beta-D-mannuronic acid (M) and alpha-L-glucuronic acid (G).
Alginic acid can form water soluble salts (alginates) with alkali metals such as sodium, potassium or lithium. These alginates are water soluble in aqueous media at pH 4, but dissociate to alginic acid at pH below 4.
Methods for recovering these water-soluble salts, particularly sodium alginate, from natural sources are well known and described, for example, in Green, U.S. Pat. No. 2,036,934 and Le Gloahec, U.S. Pat. No. 2,128,551.
Alginic acid or alginates may be chemically modified, especially with urea or urethane groups, or by hydrolysis, oxidation, esterification, etherification, sulphation, phosphorylation, amination, amidation or alkylation reactions, or by several of these modifications, to form alginic acid derivatives, including salts.
These derivatives may be anionic, cationic, amphoteric or nonionic and are capable of forming water soluble salts with alkali metals, such as sodium, potassium or lithium, to form the alkali metal salts of alginic acid derivatives.
More specifically, alginates can be reacted with alkylene oxides, such as ethylene oxide or propylene oxide, to form polyglycol alginates. The polyglycol segment is bonded to the alginate via one or more carboxyl groups. Typically, alginates are reacted with propylene oxide to form polypropylene glycol alginate (PPG alginate) and ethylene oxide to form polyethylene glycol alginate (PEG alginate). The preparation of polyglycol alginate salts is disclosed in Strong, U.S. patent No. 3,948,881, Pettitt, U.S. patent No. 3,772,266, and Steiner, U.S. patent No. 2,426,125.
Preferably, the polyglycol alginate salts have a degree of esterification of from about 40% to about 95%, more preferably from about 70% to 95%.
Suitable alginates have a weight average molecular weight of about 20,000 daltons to about 500,000 daltons. As in Martinsen et al, "comprehensive of Differencen Methods for Determination of Molecular Weights and Molecular Weight Distribution of Alginates" (Carbohydr. Polymer., 15, 171-Bukurad 193, 1991), the intrinsic viscosity is first determined and the Weight average Molecular Weight is then calculated using the Mark-Houwink Sakurad equation.
The weight average molecular weights indicated above also apply to the alkali metal salts of alginic acid derivatives.
A list of various commercially available alginates, their properties, and their sources can be found in Shapiro, U.S. patent No. 6,334,968, table 1, column 16, line 49 to column 17, line 18, incorporated herein by reference.
According to one embodiment of the invention, the alkali metal alginic acid compound may be selected from sodium alginate and potassium alginate, preferably sodium alginate.
Representative alkali alginate compounds suitable for use in the present invention may be, for example, Kelcosol, Satialgine, Cecalgum or Algogel, Karma Biopolymer, Protanal, Danisco, Grindsted®Alginate, Kimica Algin, and Manucol, ISP®And Manugel®Is a product sold under the name of the market.
Aqueous phase
The second composition according to the invention comprises at least one aqueous phase.
The at least one aqueous phase comprises water.
The aqueous phase may also comprise a water-miscible organic solvent (at room temperature: 25 ℃), for example a monoalcohol containing from 2 to 6 carbon atoms, such as ethanol or isopropanol; in particular polyols containing from 2 to 20 carbon atoms, preferably from 2 to 10 carbon atoms, preferably from 2 to 6 carbon atoms, such as glycerol, propylene glycol, butylene glycol, pentylene glycol, hexylene glycol, dipropylene glycol or diethylene glycol; glycol ethers (especially containing 3 to 16 carbons)Atom), such as mono-, di-or tri-propylene glycol (C)1-C4) Alkyl ethers, mono-, di-or tri-ethylene glycols (C)1-C4) Alkyl ethers, and mixtures thereof.
The aqueous phase may also comprise any water-soluble or water-dispersible compound compatible with the aqueous phase, such as hydrophilic gelling agents, preservatives or surfactants and mixtures thereof.
In particular, the second composition of the invention may comprise said at least one aqueous phase in a content ranging from 10% to 99% by weight, in particular from 50% to 99% by weight, more particularly from 70% to 99% by weight, relative to the total weight of the second composition.
Hydrophilic gelling agent
The second composition according to the invention may optionally comprise at least one additional hydrophilic gelling agent.
For the purposes of the present invention, the term "hydrophilic gelling agent" refers to a compound capable of gelling the aqueous phase without binding polyvalent metal ions from the first composition.
The gelling agent may be water soluble or water dispersible.
More specifically, the hydrophilic gelling agent may be chosen from synthetic polymeric gelling agents, polymeric gelling agents of natural or natural origin, or mixtures thereof.
Synthetic polymeric gelling agents
For the purposes of the present invention, the term "synthetic" means that the polymer is not a naturally occurring or naturally derived derivative of a polymer.
Synthetic polymeric gelling agents contemplated in accordance with the present invention may or may not be microparticles.
For the purposes of the present invention, the term "microparticles" when used in the synthesis of polymeric gelling agents means that the polymer is in the form of particles, preferably spherical particles.
More specifically, these polymers may be chosen in particular from:
modified or unmodified carboxyvinyl polymers, e.g. Carbopol from Goodrich®(CTFA name: Carbomer) is a product sold under the name;polyacrylates, polymethacrylates, e.g. the Lubrajel and Norgel names Guardian or Hispagel names Hispamal Chimica®A product sold under the name; polyacrylamide; optionally crosslinked and/or neutralized 2-acrylamido-2-methylpropanesulfonic acid polymers and copolymers, for example from Clariant Inc. in Hostacerin AMPS®Poly (2-acrylamido-2-methylpropanesulfonic acid) sold under the name CTFA (ammonium polyacryloyldimethyltauride); acrylamide and AMPS®In the form of a W/O emulsion, as known by Sepigel ™ 305 from SEPPIC corporation (CTFA name: polyacrylamide/C)13-14Isoparaffin/laureth-7) and the equivalent of Simulgel ™ (CTFA name: acrylamide/sodium acryloyldimethyl taurate copolymer/isohexadecane/polysorbate 80); and mixtures thereof.
Preferably, these polymers may be chosen from acrylates/acrylates C10-30Alkyl ester cross-linked polymers, e.g. Carbopol® ultrez 20、Carbopol® ultrez 21、Permulen™ TR-1、Permulen™ TR-2、Carbopol®1382、Carbopol®ETD 2020, Carbomer such as Synthalen® K、Carbopol®980. Acryloyldimethyl ammonium taurate/steareth-8 methacrylate copolymers, e.g. Aristoflex®SNC, acrylate copolymers, e.g. Carbopol®Aqua SF-1, Acryloyldimethyl ammonium taurate/Steareth-25 methacrylate crosspolymers, e.g. Aristoflex®HMS, ammonium acryloyldimethyltaurate, e.g. Aristoflex® AVC。
Preferably, these polymers may be selected from carboxyvinyl polymers, such as Carbopol®Products (carbomers), e.g. Carbopol sold by Lubrizol®Ultrez 20 Polymer, and Pemulen products (acrylate/acrylic acid C)10-30Alkyl ester copolymers); polyacrylamide, e.g. SEPPIC under the trademark Sepigel 305 (CTFA name: polyacrylamide/C)13-14Isoparaffin/laureth-7) or Simulgel-600 (CTFA name: acrylamide/acryloylSodium dimethyl taurate copolymer/isohexadecane/polysorbate 80); optionally crosslinked and/or neutralized 2-acrylamido-2-methylpropanesulfonic acid polymers and copolymers, for example Hoechst under the trademark Hostacerin AMPS®(CTFA name: Polyacryloyldimethyltauamonium) sold as poly (2-acrylamido-2-methylpropanesulfonic acid) or SEPPIC sold as Simulgel ™ 800 (CTFA name: sodium polyacryloyldimethyltaurate/polysorbate 80/sorbitan oleate); copolymers of 2-acrylamido-2-methylpropanesulfonic acid and hydroxyethyl acrylate, such as the Simulgel ™ NS and Sepinov EMT 10 sold by SEPPIC; and mixtures thereof.
Preferably, these polymers may be selected from the group consisting of glycerol acrylate/acrylic acid copolymers available under the trade name Lubrajel @fromisp Technologies, inc. (United Guardian Inc.), in particular in the form of what is known as Lubrajel @ oil, which contains about 1.0% to 1.3% glycerol acrylate/acrylic acid copolymer in aqueous glycerol solution (about 40% glycerol). Lubrajel oil also included approximately 0.6% PVM/MA copolymer (also known as methoxyethylene/maleic anhydride copolymer).
Polymeric gelling agents of natural or natural origin
For the purposes of the present invention, the term "of natural origin" is intended to mean a polymeric gelling agent obtained by modification of a natural polymeric gelling agent.
These gelling agents may be particulate or non-particulate.
More specifically, these gelling agents belong to the group of polysaccharides.
In general, the polysaccharides suitable for use in the present invention may be homopolysaccharides, if glycans, glucans, galactans and mannans, or heteropolysaccharides, such as hemicelluloses.
Similarly, they may be linear polysaccharides, such as pullulan, or branched polysaccharides, such as gum arabic and pullulan, or mixed polysaccharides, such as starch.
Generally, the polysaccharide may be selected from polysaccharides produced by microorganisms; polysaccharides isolated from algae, and higher plant polysaccharides such as homopolysaccharides, especially cellulose and its derivatives or fructans, heteropolysaccharides such as gum arabibles, galactomannans, glucomannans and their derivatives; and mixtures thereof.
In particular, the polysaccharide may be chosen from fructans, gellan (gellan), dextran, amylose, amylopectin, glycogen, pullulan, dextran, cellulose and derivatives thereof, in particular methylcellulose, hydroxyalkylcellulose, ethylhydroxyethylcellulose and carboxymethylcellulose, mannan, xylan, lignin, arabinons, galactans, polygalacturonic acid (galacturonan), chitin, chitosan, glucuronoxylan, arabinoxylans, xyloglucans, glucomannans, arabinogalactans, glycosaminoglucans (glycoamidoglucans), gum arable, tragacanth gum, gum ghatti (ghatti gums), locust bean gum, galactomannans, such as guar gum and non-ionic derivatives thereof, in particular hydroxypropyl gum and ionic derivatives thereof, biopolysaccharide gums of microbial origin (biopolysaccharide gums), in particular scleroglucan or xanthan gum, mucopolysaccharides, in particular chondroitin sulphate, and mixtures thereof. These polysaccharides can be chemically modified, in particular with urea or urethane groups, or by hydrolysis, oxidation, esterification, etherification, sulfation (sulfation), phosphorylation, amination, amidation or alkylation reactions, or by several of these modifications.
The resulting derivatives may be anionic, cationic, amphoteric or non-ionic.
Advantageously, the polysaccharide may be selected from xanthan gum, scleroglucan gum, guar gum, inulin and pullulan and mixtures thereof.
In general, such compounds useful in the present invention are selected from those described in particular in the following documents: Kirk-Othmer's Encyclopedia of Chemical Technology, third edition, 1982, volume 3, pages 896-900 and 15, pages 439-458; polymers in Nature, published by John Wiley & Sons, Chapter 6, pp 240-328, 1980, by E.A. MacGregor and C.T. Greenwood; a Book entitled Handbook of Water-solvent Gums and Resins, published by McGraw Hill Book Company (1980) and published by Industrial Gums-Polysaccharides and the third derivative, edited by Roy L. Whistler, second edition, Academic Press Inc., by Robert L. Davidson.
More precisely, the polysaccharides suitable for use in the present invention can be distinguished according to whether they are derived from microorganisms, from algae or from higher plants, and are described in detail below.
Polysaccharides produced by microorganisms
Xanthan gum
Xanthan gum is produced on an industrial scale by the bacterium Xanthomonas campestris (Xanthomonas campestris) The heteropolysaccharide produced by aerobic fermentation of (a). Like cellulose, its structure consists of a backbone of β (1,4) -linked β -D-glucose. One of the two glucose molecules carries a trisaccharide side chain consisting of alpha-D-mannose, beta-D-glucuronic acid and terminal beta-D-mannose. The internal mannose residue is typically acetylated at carbon 6. About 30% of the terminal mannose residues carry pyruvate groups attached in chelated form between carbon 4 and carbon 6. The charged pyruvic and glucuronic acids are ionizable and thus responsible for the anionic nature of xanthan gum (negative charge down to a pH equal to 1). The contents of pyruvate residues and acetate residues vary depending on the strain, the fermentation process, the conditions after fermentation and the purification steps. These groups can be used as Na in commercial products+、K+Or Ca2+Ion neutralization (Satia, 1986). The neutralized form can be converted to the acid form by ion exchange or by dialysis against an acidic solution.
Xanthan gum has a molecular weight between 1000000 and 50000000 and a viscosity (measured at 60 rpm on a brookfield viscometer of LVT type at 25 ℃) between 0.6 and 1.65 pa.s for an aqueous composition containing 1% xanthan gum.
Representative xanthan gums are, for example, Rhodia Chimie, Rhodicare, Cardill texturing Solutions, Satiaxane ™ (for the food, cosmetic and pharmaceutical industries), ADM, Novaxan @, and CP-Kelco, Kelzan @®And Keltrol®Is a product sold under the name of the market.
Pullulan polysaccharide
Pullulan is a polysaccharide composed of maltotriose units, known under the name of α (1,4) - α (1,6) -glucan. Three glucose units in maltotriose are linked via α (1,4) glycosidic bonds, while successive maltotriose units are linked to each other via α (1,6) glycosidic bonds.
Pullulan is produced, for example, by the Hayashibara group of japan under the reference Pullulan PF 20.
Dextran and dextran sulfate
Dextran is a neutral polysaccharide without any charged groups, which is biologically inert and is prepared by fermentation of sugar beet sugar containing only hydroxyl groups. Dextran fractions of different molecular weights can be obtained from native dextran by hydrolysis and purification. The dextran may particularly be in the form of dextran sulfate.
Dextran is represented, for example, by products sold under the name Dextran or Dextran T by Pharmacosmos or Dextran 70 Powder by Meito Sangyo co. Dextran sulfate is sold under the name Dextran sulfate by the PK Chemical A/S company.
Succinoglycans
Succinoglycan is a high molecular weight extracellular polymer produced by bacterial fermentation, consisting of octasaccharide repeat units (8-saccharide repeats). Succinoglycans are sold, for example, by the company Rhodia under the name Rheozan.
Scleroglucan
Scleroglucan is a non-ionic branched homopolysaccharide composed of β -D-glucan units. The molecule consists of a linear backbone formed of D-glucose units linked via β (1,3) bonds, and wherein one third are linked to a pendant D-glucose unit via β (1,6) bonds.
A more complete description of scleroglucan and its preparation can be found in patent US 3301848.
Scleroglucan is for example sold by Alban Miiller under the name of Amigel or by Cargill under the name of Actigum ™ CS.
Polysaccharides isolated from algae
Furcellaran
Furcellaran is commercially obtained from the red alga furcellaran (Furcellaria fasztisiata). Furcellaran is produced, for example, by the company Est-Agar.
Polysaccharides of higher plants
This class of polysaccharides can be divided into homogeneous polysaccharides (only one saccharide) and heterogeneous polysaccharides consisting of several types of saccharides.
a) Homogeneous polysaccharides and derivatives thereof
The polysaccharide according to the invention may be selected from cellulose and derivatives or fructans.
Cellulose and derivatives
The polysaccharide according to the invention can also be cellulose or derivatives thereof, especially cellulose ethers or esters (e.g. methylcellulose, carboxymethylcellulose, hydroxymethylcellulose, hydroxyethylcellulose, hydroxypropylcellulose, hydroxymethylpropylcellulose, cellulose acetate, cellulose nitrate, nitrocellulose).
The present invention may also contain cellulose-based associative polymers.
According to the present invention, the term "cellulose-based compound" refers to any polysaccharide compound with a linear sequence of anhydroglucopyranose residues (AGU) linked together via β (1,4) linkages in its structure. The repeating unit is a cellobiose dimer. AGU is in chair conformation and carries 3 hydroxyl functions: 2 secondary alcohols (at positions 2 and 3) and one primary alcohol (at position 6). The polymers thus formed are bound together via intermolecular bonds of the hydrogen bond type, thereby providing cellulose with a fibrous structure (about 1500 molecules per fiber).
Depending on the source of the cellulose, the degree of polymerization varies greatly; which may have values of several hundred to several tens of thousands.
The hydroxyl groups of cellulose can be reacted, partially or completely, with various chemical reagents to produce cellulose derivatives with inherent properties. The cellulose derivative may be anionic, cationic, amphoteric or non-ionic. Among these derivatives, cellulose ethers, cellulose esters and cellulose ester ethers are distinguished.
Among the nonionic cellulose ethers, mention may be made of alkyl celluloses, such as methyl cellulose and ethyl cellulose; hydroxyalkyl celluloses such as hydroxymethyl cellulose, hydroxyethyl cellulose and hydroxypropyl cellulose; and mixed hydroxyalkyl alkylcelluloses such as hydroxypropylmethylcellulose, hydroxyethylmethylcellulose, hydroxyethylethylcellulose and hydroxybutylmethylcellulose.
According to the invention, hydroxyalkyl cellulose as nonionic cellulose ether belongs to the class of nonionic polysaccharides, so that it can be used as water-soluble polyhydroxyl polymer to soften hydroxyl-rich fibers. Thus, according to one embodiment of the invention, the first composition comprises hydroxyl-rich fibers and the second composition comprises hydroxyalkyl cellulose.
Among anionic cellulose ethers, mention may be made of carboxyalkyl celluloses and their salts. For example, carboxymethyl cellulose, carboxymethyl methyl cellulose and carboxymethyl hydroxyethyl cellulose and their sodium salts may be mentioned.
Among the cationic cellulose ethers, mention may be made of crosslinked or non-crosslinked quaternized hydroxyethyl cellulose.
The quaternizing agent may in particular be glycidyltrimethylammonium chloride or a fatty amine, such as laurylamine or stearylamine. Another cationic cellulose ether which may be mentioned is hydroxyethyl cellulose hydroxypropyl trimethylammonium.
Quaternized cellulose derivatives are in particular:
quaternized cellulose modified with groups comprising at least one fatty chain, such as alkyl, arylalkyl or alkylaryl groups comprising at least 8 carbon atoms, or mixtures thereof,
-quaternized hydroxyethylcellulose modified with groups comprising at least one fatty chain, such as alkyl, arylalkyl or alkylaryl groups comprising at least 8 carbon atoms, or mixtures thereof.
The alkyl groups carried by the above-mentioned quaternized cellulose or hydroxyethylcellulose preferably contain 8 to 30 carbon atoms. Aryl preferably means phenyl, benzyl, naphthyl or anthracenyl.
May indicate the presence of C8-30Examples of fatty chain quaternized alkyl hydroxyethyl celluloses include Quatrioft LM 200, Quatrioft LM-X529-18-A, Quatrioft LM-X529-18B (C) products sold by Amerchol12Alkyl) and Quatrioft LM-X529-8 (C)18Alkyl), and the products Crodacel QM, Crodacel QL (C) sold by Croda corporation12Alkyl) and Crodacel QS (C)18Alkyl groups).
Among the cellulose derivatives, mention may also be made of:
cellulose modified with groups comprising at least one fatty chain, for example with groups comprising at least one fatty chain, such as alkyl, especially C8-22Alkyl-, arylalkyl-and alkylaryl-modified hydroxyethylcellulose, such as the Natrosol Plus Grade 330 CS (C) sold by Aqualon16Alkyl), and
cellulose modified with polyalkylene glycol alkylphenyl ether groups, such as the product Amercell Polymer HM-1500 (nonylphenylpolyethylene glycol (15) ether) sold by the company Amerchol.
Cellulose esters include inorganic cellulose esters (cellulose nitrate, sulfate, phosphate, etc.), organic cellulose esters (cellulose monoacetate, triacetate, amido propionate, acetate butyrate, acetate propionate, acetate trimellitate, etc.), and mixed organic/inorganic cellulose esters such as cellulose acetate butyrate sulfate and cellulose acetate propionate sulfate. Among the cellulose ester ethers, mention may be made of hydroxypropylmethylcellulose phthalate and ethylcellulose sulfate.
The cellulose-based compound of the present invention may be selected from unsubstituted cellulose and substituted cellulose. Representative of cellulose and derivatives are, for example, the FMC Biopolymers company Avicel®The name of (microcrystalline cellulose, MCC), the name of Cekol (carboxymethyl cellulose) by Noviant (CP-Kelco), the name of Akzo Nobel, the name of Akucell AF (sodium carboxymethyl cellulose), the name of Methocel (cellulose ether) by Dow, and the name of Ethocel (Ethyl cellulose)Plain) as the name and Aqualon from Hercules Aqualon®(carboxymethylcellulose and sodium carboxymethylcellulose), Benecel®(methylcellulose), Blanose [ (carboxymethylcellulose), Culminal [ [ sic ] N-acetyl-L-methyl-L-acetyl-L-methyl-L-acetyl-L-D-methyl-L-acetyl-L-methyl-L-methyl-cellulose®(methyl cellulose, hydroxypropyl methyl cellulose), Klucel®(hydroxypropyl cellulose), Polysurf®(cetyl hydroxyethylcellulose) and Natrosol®CS (hydroxyethyl cellulose) is a product sold under the name CS.
Fructosan
The polysaccharide according to the invention may in particular be a fructan selected from inulin and its derivatives (in particular dicarboxy inulin and carboxymethyl inulin).
Fructans (fructans) or fructans (fructans) are oligosaccharides or polysaccharides that comprise a sequence of anhydrofructose units optionally in combination with several sugar residues other than fructose. The fructans may be linear or branched. Fructans can be products obtained directly from plant or microbial sources, or products whose chain length has been modified (increased or decreased) by fractionation, synthesis or hydrolysis, in particular by enzymatic methods. Fructans typically have a degree of polymerization of from 2 to about 1000, preferably from 2 to about 60.
Three classes of fructans were distinguished. The first class corresponds to products whose fructose units are predominantly linked via β (2,1) bonds. These are substantially linear fructans, for example inulin.
The second class also corresponds to linear fructose, but the fructose units are essentially linked via β (2,6) bonds. These products are levans (levans).
The third class corresponds to mixed fructans, i.e. containing β (2,6) and β (2,1) sequences. These are essentially branched fructans, such as, for example, rye polyfructose (graminans).
The preferred fructan in the composition according to the invention is inulin. Inulin may be obtained, for example, from chicory, dahlia or Jerusalem artichoke (Jerusalem artichoke), preferably from chicory.
In particular, polysaccharides, in particular inulin, have a degree of polymerization of from 2 to about 1000, preferably from 2 to about 60, and a degree of substitution of less than 2, based on one fructose unit.
Representative of inulin for use in the present invention are, for example, inulin from Beneo ™ by Orafti, and Frutafit by Sensus®Is a product sold under the name of the market.
b) Heteropolysaccharides and derivatives thereof
The polysaccharide which may be used according to the invention may be a gum, such as cassia gum, karaya gum, konjac gum, tragacanth gum, tara gum, acacia gum or acacia gum.
Arabic gum
Gum arabic is a highly branched acidic polysaccharide in the form of a mixture of potassium, magnesium and calcium salts. The monomer units of the free acid (arabinonic acid) are D-galactose, L-arabinose, L-rhamnose and D-glucuronic acid.
Galactomannans (guar gum, locust bean gum, fenugreek gum, tara gum) and derivatives (guar phosphate, hydroxypropyl guar, etc.)
Galactomannans are nonionic polyglycosides extracted from the endosperm of leguminous seeds, which constitute storage carbohydrates of leguminous seeds.
Galactomannans are macromolecules consisting of a backbone of β (1,4) -linked D-galactopyranose units with pendant side branches consisting of single D-galactopyranose units linked α (1,6) to the backbone. The various galactomannans differ firstly in the proportion of alpha-D-galactopyranose units present in the polymer and secondly in the significant difference in the distribution of the galactose units along the mannose chains.
Guar gum has a mannose/galactose (M/G) ratio of about 2, tara gum has a mannose/galactose (M/G) ratio of 3, and locust bean gum has a mannose/galactose (M/G) ratio of 4.
Guar gum
Guar gum is characterized by a mannose/galactose ratio of about 2/1. The galactose groups are regularly distributed along the mannose chains.
The guar gums that can be used according to the present invention can be nonionic, cationic or anionic. According to the invention, chemically modified or unmodified non-ionic guar gums can be used.
Unmodified non-ionic guar gums are for example the Vidogum GH, Vidogum G and Vidocrem company of Unipectine, the Jaguar company of Rhodia, the Meypro company of Danisco®Guar as the name, Viscogum ™ by Cargill Inc. and Supercol by Aqualon Inc®Guar gum is a product sold under the name guar gum.
Representative of the hydrolysed non-ionic guar that can be used according to the invention are for example the ones available from Danisco as mepyrodor®Is a product sold under the name of the market.
The modified non-ionic guar which can be used according to the invention is preferably selected from C1-C6Hydroxyalkyl modification, among which mention may be made, for example, of hydroxymethyl, hydroxyethyl, hydroxypropyl and hydroxybutyl.
Such non-ionic guar gums optionally modified with hydroxyalkyl groups are for example available under the trade names Jaguar HP 60, Jaguar HP 105 and Jaguar HP 120 (hydroxypropyl guar) from Rhodia or N-Hance from Aqualon®HP (hydroxypropyl guar) is sold under the name HP.
The cationic galactomannan gum preferably has a cationic charge density of less than or equal to 1.5 meq./g, more particularly between 0.1 and 1 meq./g. The charge density can be determined by the Kjeldahl method. Which typically corresponds to a pH of about 3 to 9.
Generally, for the purposes of the present invention, the term "cationic galactomannan gum" refers to any galactomannan gum containing cationic groups and/or groups ionizable into cationic groups.
Preferred cationic groups are selected from those comprising primary, secondary, tertiary and/or quaternary amine groups.
The cationic galactomannan gum used will generally have a viscosity of from about 500 to 5X 106Preferably between about 103To 3X 106Weight average molecular mass between.
Cationic galactomannan gums which may be used in accordance with the present invention are, for example, those comprising a tri (C)1-4) Gums for alkylammonium cationic groups. Preferably, the hydroxyl functions of these gumsFrom 2% to 30% of the energy content carries trialkylammonium cationic groups.
Among these trialkylammonium groups, mention may be made most particularly of the trimethylammonium and triethylammonium groups.
More preferably, these groups represent from 5% to 20% by weight relative to the total weight of the modified galactomannan gum.
According to the invention, the cationic galactomannan gum is preferably a guar gum comprising hydroxypropyl trimethylammonium groups, i.e. a guar gum modified, for example, with 2, 3-epoxypropyltrimethylammonium chloride.
These galactomannan gums, in particular guar gums modified with cationic groups, are products known per se and are described, for example, in patents US 3589578 and US 4031307. Furthermore, these products are in particular marketed by Rhodia under the trade names Jaguar EXCEL, Jaguar C13S, Jaguar C15, Jaguar C17 and Jaguar CI 62 (guar hydroxypropyltrimonium chloride), by Degussa under Amilan®Guar (Guar hydroxypropyltrimonium chloride) as name and N-Hance by Aqualon®3000 (guar hydroxypropyltrimonium chloride) is sold under the name guar gum.
Anionic guar gums which can be used according to the present invention are polymers comprising groups derived from carboxylic, sulfonic, sulfenic, phosphoric, phosphonic or pyruvic acids. The anionic group is preferably a carboxylic acid group. The anionic groups may also be in the form of acid salts, especially sodium, calcium, lithium or potassium salts.
The anionic guar that can be used according to the invention is preferably a carboxymethyl guar derivative (carboxymethyl guar or carboxymethyl hydroxypropyl guar).
Locust bean gum
Locust bean gum is extracted from the seeds of the locust bean (Ceratonia siliqua).
Unmodified locust bean gums useful in the present invention are for example the Viscogon ™ by Cargill, Vidogum L by Unipektin and Grinsted by Danisco®LBG is sold under the name LBG.
Representative of chemically modified locust bean gums useful in the present invention can be, for example, the cationic locust bean gum sold under the name Catinal CLB (locust bean gum hydroxypropyl trimethyl ammonium chloride) by the company Toho.
Tara glue
Tara gum useful in the context of the present invention is sold, for example, by Unipektin under the name Vidogum SP.
Glucomannan (konjak glue)
Glucomannans are polysaccharides with high molecular weights (500000 < M glucomannan < 2000000) consisting of D-mannose and D-glucose units, which have a branch of about every 50 or 60 units. It is present in wood, but is also the main component of konjac gum. Amorphophallus konjac (Amorphophalus konjac) is a plant of the Araceae family.
Products which can be used according to the invention are, for example, Propol by Shimizu®And Rheolex®Sold under the name of Vietnam.
Other polysaccharides
Among the other polysaccharides that can be used according to the invention, mention may also be made of chitin (poly-N-acetyl-D-glucosamine, β (1,4) -2-acetamido-2-deoxy-D-glucose), chitosan and derivatives (chitosan- β -glycerophosphate, carboxymethylchitin, etc.), such as those sold by the company France-Chitine; glycosaminoglycans (GAGs) such as hyaluronic acid, chondroitin sulfate, dermatan sulfate, keratan sulfate, preferably hyaluronic acid; xylans (or arabinoxylans) and derivatives.
Arabinoxylans are polymers of xylose and arabinose, both classified under the name pentosan. Xylans consist of a backbone of β (1,4) linked D-xylose units, and three substituents are present on them (Rouau & Thibault, 1987): the acid units, alpha-L-arabinofuranose units, may contain side chains of arabinose, xylose, galactose and glucuronic acid.
According to this variant, the polysaccharide is preferably hyaluronic acid or a salt thereof.
The at least one hydrophilic gelling agent may be present in an amount of, for example, 0.001 to 10 wt. -%, preferably 0.01 to 5 wt. -%, more preferably 0.05 to 3 wt. -%, relative to the total weight of the second composition.
Active agent
According to one embodiment of the invention, the first composition may comprise at least one active agent.
According to one embodiment of the invention, the second composition may comprise at least one active agent.
When the first composition comprises the at least one active agent, it may be incorporated into the first composition, in particular by means of an alternating electric field. The one or more active agents may be incorporated in particular in the powder state.
Among all the active agents which can be used in the present invention, mention may be made in particular of: alpha-or beta-hydroxy acids, such as lactic acid, glycolic acid, citric acid, 5-octanoylsalicylic acid, alpha-hydroxydecanoic acid, alpha-hydroxylauric acid, tartaric acid, glucuronic acid, galacturonic acid, acrylic acid, alpha-hydroxybutyric acid, alpha-hydroxyisobutyric acid, malic acid, mandelic acid, phosphoric acid, pyruvic acid, lactobionic acid and salicylic acid.
Anti-acne agents such as salicylic acid or benzoyl peroxide, octopirox, dextro-and levorotatory sulfur-containing amino acids, their salts and their N-acetyl derivatives such as N-acetylcysteine, or agents intended to prevent skin aging and/or to improve the condition thereof, such as the above-mentioned alpha-and beta-hydroxy acids, retinoids such as retinoic acid, retinol and its esters, such as retinol propionate and retinol acetate, or retinol palmitate, niacinamide, allantoin, aloe vera extract, azelaic acid, bisabolol, phytic acid, collagen, or agents that stimulate collagen formation, vitamins such as vitamin C or its derivatives, such as ascorbyl glucoside, vitamin E or its derivatives, vitamin A or its derivatives, vitamin F or its derivatives, dextro-and levorotatory sulfur-containing amino acids and its derivatives, such as mentioned above, may also be used, Elastin, N-acetyl D-glucosamine, luteolin or antioxidants, such as green tea or active fractions thereof, glycerol, laponite, caffeine, essential oils (essential oils), colorants, radical scavengers, moisturizers, depigmenting agents (depigmenting agents), agents for improving the complexion, such as artificial tanning agents of the dihydroxyacetone or tyrosine ester type, sebum regulators (lipomodulators), softeners, anti-wrinkle agents, keratolytic agents, refreshing agents (fresheners), deodorants, anesthetics, nutritional agents and mixtures thereof. Bleaching agents (bleaching agents) such as kojic acid, ascorbyl phosphate, ascorbyl glucoside, ascorbic acid and mixtures thereof may also be used.
In the case of a mask, it is also possible to use active agents for improving the skin condition, such as moisturizers or agents which contribute to improving the natural lipid barrier, such as ceramides, cholesterol sulfates and/or fatty acids and mixtures thereof. Enzymes active on the skin, such as proteases, lipases, cerebrosidases and/or melanases and mixtures thereof, may also be used.
As further examples of active agents that may be suitable for use in the practice of the present invention are pharmaceutical agents (agents for drugs), peptides, proteins, detectable labels (detectible labels), contrast agents, analgesics, anesthetics, antibacterial agents, anti-yeast agents, antifungal agents, antiviral agents, anti-dermatitis agents, antipruritics, antiemetics, vasoprotectants, anti-motion agents, anti-irritants, anti-inflammatory agents, immunomodulators, anti-hyperkeratotic agents (anti-hyperkeratotic agents), dry skin treatments, antiperspirants, anti-psoriasis agents, anti-dandruff agents, anti-aging agents, anti-asthmatic agents and bronchodilators, sunscreens, antihistamines, healing agents, corticosteroids, tanning agents (tanning agents) and mixtures thereof.
The amount of the at least one active agent in the first composition and/or the second composition may be adjusted according to the intended use of the kit.
Alkali metal hyaluronic acid compound
Hyaluronic acid compounds may also be used as active agents according to the invention. The hyaluronic acid compound is preferably an alkali metal hyaluronic acid compound.
The term "alkali metal hyaluronic acid compound" especially refers to an alkali metal salt of hyaluronic acid (hyaluronate) or a derivative thereof. The alkali metal hyaluronate compound is water soluble.
In the context of the present invention, the term "hyaluronic acid or derivative thereof" specifically covers the basic unit of hyaluronic acid of the formula:
it is the smallest fraction of hyaluronic acid (fraction) containing the disaccharide dimer, D-glucuronic acid and N-acetylglucosamine.
The term "hyaluronic acid or derivative thereof" also comprises, in the context of the present invention, linear polymers comprising the above-mentioned polymeric units linked together in the chain via alternating β (1,4) and β (1,3) glycosidic bonds, the molecular weight (Mw) of which may be between 380 and 13000000 daltons. Such molecular weight depends to a large extent on the source of the hyaluronic acid obtained and/or the method of preparation.
In the natural state, hyaluronic acid is present in pericellular gels (mammalian gels), in the matrix of connective tissues of vertebrate organs, such as the dermis and epithelial tissues, and in particular in the epidermis, in the synovial fluid of joints, in vitreous humor, in human umbilical cords and in the processes of cockscomb protrusions (crista galli inophyssis).
Thus, the term "hyaluronic acid or derivative thereof" encompasses all fractions or subunits (subbunits) of hyaluronic acid having a molecular weight in particular within the molecular weight range highlighted above.
As an illustration of the various hyaluronic acid fractions, reference may be made to the document "Hyaluronan fragments: an information-rich system", R.Stern et al, European Journal of Cell Biology 58 (2006) 699-715, which reviews the listed biological activities of hyaluronic acid on the basis of molecular weight.
According to a preferred embodiment of the invention, the hyaluronic acid fraction suitable for the uses covered by the invention has a molecular weight between 50000 and 5000000 Da, in particular between 100000 and 5000000 Da, especially between 400000 and 5000000 Da. In this case, the term used is high molecular weight hyaluronic acid.
Alternatively, the hyaluronic acid fraction, also suitable for the uses covered by the present invention, has a molecular weight between 50000 and 400000 Da. In this case, the term used is medium molecular weight hyaluronic acid.
Still alternatively, the hyaluronic acid fraction applicable for the uses contemplated by the present invention has a molecular weight of less than 50000 Da. In this case, the term used is low molecular weight hyaluronic acid.
Finally, the term "hyaluronic acid or derivatives thereof" also comprises hyaluronic acid esters, in particular those in which all or part of the carboxyl groups of the acid functions are esterified with oxyethylenated alkyl groups or alcohols containing from 1 to 20 carbon atoms, in particular with a degree of substitution at the level of D-glucuronic acid of hyaluronic acid of from 0.5 to 50%.
More specifically, hyaluronic acid or hyaluronate may be reacted with alkylene oxides, such as ethylene oxide or propylene oxide, to form polyglycol hyaluronates. The polyglycol segment is bonded to the hyaluronic acid via a carboxyl group. Typically, hyaluronic acid or hyaluronate is reacted with propylene oxide to form polypropylene glycol hyaluronate and ethylene oxide to form polyethylene glycol hyaluronate.
Mention may also be made of the methyl, ethyl, n-propyl, n-pentyl, benzyl and dodecyl esters of hyaluronic acid. These esters are described in particular in D.Campoccia et al, "semi synthetic resinous materials from hydrophilic animal discovery", Biomaterials 19 (1998) 2101-2127.
The molecular weights indicated above also apply to the hyaluronic acid esters.
Auxiliary agent
In a known manner, the second composition of the invention may also contain adjuvants commonly found in cosmetics and/or dermatology, such as preservatives, antioxidants, pH regulators (acidic or basic), fragrances, fillers, bactericides, odor absorbers, colorants (pigments and dyes), emulsifiers and lipid vesicles.
Needless to say, the person skilled in the art will take care to select this or these optional further compounds and/or the amounts thereof such that the contemplated addition does not or substantially does not adversely affect the benefits of the second composition according to the invention.
Galenic form (Galenic form)
The second composition according to the invention can be in various forms, in particular in the form of an aqueous solution, dispersion or emulsion, such as in particular a water/oil or oil/water emulsion or a multiple emulsion.
The emulsion may have an oily or aqueous continuous phase. Such emulsions may be, for example, inverse (W/O) or direct (O/W) emulsions, or multiple emulsions (W/O/W or O/W/O).
In the case of emulsions, direct (O/W) emulsions are preferred.
In particular, the second composition according to the invention may be in the form of an oil-in-water (O/W) emulsion, a water-in-oil (W/O) emulsion or a multiple emulsion, preferably an oil-in-water (O/W) emulsion.
The second composition of the present invention is preferably an aqueous solution.
According to a preferred embodiment of the invention, the kit is presented as a mask, comprising:
1) nonwoven (or tissue) made from hydroxyl-rich fibres comprising from 0.01 to 5 wt. -%, preferably from 0.02 to 1 wt. -% or preferably from 0.04 to 0.5% of calcium sulphate or calcium carbonate and from 0.001 to 1 wt. -%, in particular from 0.01 to 0.1 wt. -%, like from 0.01 to 0.06% of HEC or HPC, relative to the total weight of the nonwoven, and
2) a composition comprising, relative to the total weight of the composition, from 10% to 99% by weight, preferably from 50% to 99% by weight, of at least one aqueous phase, from 0.1% to 0.5% by weight, preferably from 0.1% to 0.3% by weight, of sodium alginate and from 0.1% to 0.5% by weight, preferably from 0.2% to 0.4% by weight, of sodium citrate,
wherein the weight ratio of the nonwoven fabric to the composition is from 1:3 to 1:20, preferably from 1:8 to 1: 15.
Different embodiments of the suit
Based on the discussion of a kit comprising a first composition and a second composition according to the present invention, it is to be understood that the following embodiments are also within the spirit of the present invention.
Specifically, according to the present invention, there is provided a mask pack 1 comprising:
1) a first composition comprising at least one water-insoluble polyvalent metal salt and at least one water-soluble polyhydroxy polymer, and
2) a fourth composition free of water comprising:
a) at least one water-soluble polyvalent metal ion chelating agent, and
b) at least one water-soluble gelling agent capable of forming a gel with the polyvalent metal ion,
wherein the first composition and the fourth composition are disposed separately from each other.
For such a mask pack 1, the first composition and its components, including the water-insoluble salt and the water-soluble polyhydroxy polymer, and the fourth composition, including the water-soluble chelating agent, the water-soluble gelling agent, and the like, may be substantially the same as the set of the present invention, wherein the fourth composition is substantially equivalent to the second composition except for the absence of water. The construction of the mask pack 1 can also be substantially the same as the kit of the present invention. In addition, the amount of the composition, the components of the composition, and the ratios therebetween of the mask pack 1 can be referenced to the kit of the present invention.
To apply the mask package 1, the fourth composition can be mixed with water to form an aqueous solution of the fourth composition. Obviously, such an aqueous solution substantially corresponds to the second composition of the kit according to the invention. This aqueous solution is then mixed with the first composition, for example with reference to the way of mixing the first and second compositions of the kit according to the invention.
In particular, the mask pack 1 according to the present invention comprises:
1) a nonwoven fabric (or tissue) comprising, relative to the total weight of the nonwoven fabric, 0.01 to 5 wt. -%, preferably 0.02 to 1 wt. -% or preferably 0.04 to 0.5% of calcium sulfate or calcium carbonate and 0.001 to 1 wt. -%, in particular 0.01 to 0.1 wt. -%, like 0.01 to 0.06% of HEC or HPC, and
2) a water-free fourth composition comprising, relative to the total weight of the composition, from 0.1% to 0.5%, preferably from 0.1% to 0.3%, by weight of a water-soluble chelating agent and from 0.1% to 0.5%, preferably from 0.2% to 0.4%, by weight of a water-soluble gelling agent,
wherein the weight ratio of nonwoven to fourth composition is from 1:3 to 1:20, preferably from 1:8 to 1: 15.
Method and use
The first and second/fourth compositions according to the invention can generally be prepared according to the general knowledge of a person skilled in the art. However, it will be appreciated that the skilled person can select a method of preparation based on his general knowledge, taking into account the nature of the ingredients used, for example their solubility in the vehicle and the use envisaged for the composition or kit.
According to one embodiment, the kit according to the invention can be used for caring for keratin materials, in particular the face. Such use may be represented by a method for caring for keratin materials, in particular the face, comprising the steps of compounding the first and second compositions of the kit in a predetermined weight ratio, and then applying the mixture thus obtained as a mask on the keratin materials.
According to one embodiment, the kit according to the invention may be used for managing skin wounds, for preventing post-operative adhesion formation or for filling or repairing osteochondral defects, or the like. Such use may be represented by a method for managing skin wounds, preventing post-operative adhesion formation or filling or repairing osteochondral defects comprising the steps of compounding the first and second compositions of the kit in a predetermined weight ratio and then applying as a mask or tampon (stuffing) to the site where the mixture thus obtained is needed.
Notwithstanding that the numerical ranges and parameters setting forth the broad scope of the invention are approximations, the numerical values set forth in the specific examples are reported as precisely as possible. Any numerical value, however, inherently contains certain errors necessarily resulting from the standard deviation found in their respective measurements. The following examples are intended to illustrate the invention without thereby limiting its scope.
Examples
The amounts/concentrations of the ingredients in the compositions/formulations described below are expressed in weight% relative to the total weight of each composition/formulation.
Example 1
I. Preparation of
As a second composition, inventive formulations a and B and comparative formulation a were prepared.
TABLE 1
In table 1, comparative a contains no trisodium citrate, compared to inventive formulation a.
Procedure for preparing a second composition using the formulation in table 1: all ingredients were placed in a beaker, heated to 60 ℃ and homogenized until homogeneous, and cooled to room temperature.
The preparation procedure of the facial mask comprises the following steps: 0.75 grams each of formulations a through B and comparative a, respectively, were placed together with a nonwoven fabric weighing 1.3 grams made from 20% by weight calcium alginate fibers and 80% lyocell fibers sold by the company Sanjiang under the name M762R-40 CN.
Evaluation of the inventive mask and comparative mask
The masks of the present invention and the comparative mask were evaluated using the following procedures.
Texture transformation evaluation method
Five panelists visually rated the gelled area on the paper towel and ranked from poor to excellent, based on the average of the ratings into the following four categories: "excellent" (> 50%), "good" (30-50%), "normal" (10-30%) or "poor" (< 10%).
Freshness evaluation method
Five panelists evaluated the degree of greasiness of the skin by tactile means while the face was gently moved to the finger abdomen.
Evaluation method the mask was applied to the face for 15 minutes and then removed and the skin massaged. The greasy feeling of the skin was perceived by moving the finger belly on the face. Each reviewer then gives scores 0 through 15. The less greasy the feel, the higher the score given.
Evaluation indexes are as follows: we graded from poor to excellent, based on scores, into the following four categories: "excellent" (> 12), "good" (8-12), "general" (4-8), and "poor" (0-4).
Skin adhesion evaluation method
Five panelists visually evaluated the degree of attachment of the mask to the face and the amount of air bubbles around the eyes, nose and mouth with a mirror under standardized lighting.
Evaluation method the mask was applied to the face and the amount of air bubbles around the eyes, nose and mouth was observed. Each reviewer then gives scores 0 through 15. The fewer bubbles, the higher the fraction given.
Evaluation indexes are as follows: we graded from poor to excellent, based on scores, into the following four categories: "excellent" (> 12), "good" (8-12), "general" (4-8), and "poor" (0-4).
Hydration effect evaluation method
Five panelists evaluated the hydration of the mask based on the fullness (plumpy), fine line improvement and soft skin provided by the formula.
Evaluation method the mask was applied to the face for 15 minutes and then removed and the skin massaged. The degree of wrinkles on the forehead and nasolabial folds were observed, the cheeks were touched with the index and middle fingers and skin softness was perceived by tactile means, and the degree of fine lines on the cheeks was observed. Each panelist gave a score of 0 to 15. The more full the skin, the higher the score given.
Evaluation indexes are as follows: we graded from poor to excellent, based on scores, into the following four categories: "excellent" (> 12), "good" (8-12), "general" (4-8), and "poor" (0-4).
Method for evaluating moisture delivery capability
Five panelists visually evaluated the amount of sap left on the skin after removing the mask with a mirror under standardized lighting.
Evaluation method the mask was applied to the face for 15 minutes and then removed. The amount of juice left on the skin was visually observed. Each reviewer then gives scores 0 through 15. The more juice left on the skin, the higher the score given.
Evaluation indexes are as follows: we graded from poor to excellent, based on scores, into the following four categories: "excellent" (> 12), "good" (8-12), "general" (4-8), and "poor" (0-4).
The results obtained are detailed in the following table:
TABLE 2
Formulation A | Formulation B | Comparative formulation A | |
Texture transformation | Good effect | Is excellent in | Difference (D) |
Adhesion to skin | Is excellent in | Is excellent in | In general |
Sense of freshness | Is excellent in | In general | Good effect |
Hydration effect | Good effect | Is excellent in | In general |
Moisture delivery capacity | Is excellent in | In general | Difference (D) |
Conclusion III
The mask of the present invention is superior to the comparative mask in beneficial properties such as texture change, hydration effect and moisture delivery ability.
Example 2:
as a first composition, inventive formulation C and comparative formulations B-D were prepared.
TABLE 3
The preparation procedure of the facial mask comprises the following steps: 0.75 grams of formula A was placed together with a nonwoven fabric weighing 1.3 grams made from formula C and comparative formulas B-D, respectively, to provide mask C and comparative masks B-D, respectively.
Evaluation of the inventive mask and comparative mask
The masks of the present invention and the comparative mask were evaluated using the following procedures.
Method for evaluating softness
(1) Five panelists evaluated the gelled area on the tissue by hand and graded from poor to excellent, based on the average of the grades, into the following 3 categories: "excellent" (uniformly softened), "normal" (softened but not uniform), or "poor" (not softened).
TABLE 4
Face pack C | Comparative mask B | Comparative mask C | Comparative mask D | |
Evaluation of | Is excellent in | In general | In general | Difference (D) |
(2) The softening effect is indirectly evaluated by measuring the deformation of the mask, since a softened mask causes deformation.
Deformation (%) = ((value measured after fresh mixing) - (initial value))/(initial value).
TABLE 5
Face pack C | Comparative mask B | |
Deformation of | 13.80% | 8.42% |
Conclusion III
The mask of the present invention is superior to the comparative mask in softness.
The foregoing description illustrates and describes the present disclosure. Additionally, the disclosure shows and describes only the preferred embodiments of the disclosure, but as mentioned above, it is to be understood that variations or modifications can be made which are within the scope of the concepts as expressed herein, commensurate with the above teachings and/or the skill or knowledge of the relevant art. The previous description is further intended to explain the best mode known of practicing the disclosure and to enable others skilled in the art to utilize the disclosure in such, or other, embodiments and with the various modifications required by the particular applications or uses disclosed herein. Accordingly, the description is not intended to limit the disclosure to the form disclosed herein. It is also intended that the appended claims be construed to include alternative embodiments.
All publications, patents, and patent applications cited in this specification are herein incorporated by reference for any and all purposes as if each individual publication, patent, or patent application were specifically and individually indicated to be incorporated by reference. In the event of inconsistencies, the present disclosure controls.
Claims (34)
1. A kit, comprising:
1) a first composition comprising at least one water-insoluble polyvalent metal salt and at least one water-soluble polyhydroxy polymer, and
2) a second composition comprising at least one aqueous phase, and
a) optionally, at least one water-soluble polyvalent metal ion chelating agent, and
b) at least one water-soluble gelling agent capable of forming a gel with the polyvalent metal ion;
wherein the first composition and the second composition are placed apart from each other.
2. The kit according to claim 1, wherein the gelling agent is specifically selected to have a lower ability to bind to polyvalent metal ions than the chelating agent.
3. Kit according to any of the preceding claims, wherein the water-insoluble multivalent metal salt is selected from water-insoluble salts of calcium, strontium, zinc, copper, manganese or mixtures thereof.
4. The kit according to any of the preceding claims, wherein the at least one water-insoluble polyvalent metal salt is a water-insoluble calcium salt selected from the group consisting of calcium alginate, calcium sulfate and calcium carbonate or mixtures thereof.
5. A kit according to any one of the preceding claims wherein the water-soluble polyhydroxy polymer comprises a polyhydroxy carboxylic acid, an acid ester; a polyhydroxycellulose or a mixture thereof, preferably hydroxyethylcellulose, hydroxypropylcellulose, hydroxypropylmethylcellulose, hydroxyethylmethylcellulose, hydroxyethylethylcellulose or hydroxybutylmethylcellulose.
6. A kit according to any one of the preceding claims, wherein the first composition of the invention comprises the at least one water-soluble polyhydroxypolymer in a content ranging from 0.001% to 1% by weight, in particular from 0.01% to 0.1% by weight, such as from 0.01% to 0.06%, relative to the total weight of the first composition.
7. The kit according to any one of the preceding claims, wherein the first composition further comprises additional hydroxyl-rich fibers, preferably regenerated cellulose or cotton fibers, wherein the at least one water-insoluble polyvalent metal salt and the at least one water-soluble polyhydroxyl polymer are loaded onto the additional fibers.
8. The kit according to claim 7, wherein the water-insoluble polyvalent metal salt is in the form of a fiber which is formed into a water-insoluble substrate with one or more additional fibers, the water-soluble polyhydric polymer being loaded onto the substrate.
9. Kit according to claim 8, wherein the water insoluble substrate comprises water insoluble polyvalent metal salt fibers in an amount of from 10 to 80 wt. -%, in particular from 10 to 40 wt. -%, and the at least one further fiber in an amount of from 10 to 80 wt. -%, in particular from 50 to 80 wt. -%, relative to the total weight of the water insoluble substrate.
10. The kit of claim 7 wherein one or more additional fibers are formed into a water insoluble substrate to which both the water insoluble multivalent metal salt and the water soluble polyhydroxy polymer are applied.
11. Kit according to claim 10, wherein the water insoluble substrate comprises water insoluble polyvalent metal salt fibers in an amount of from 0.01 to 5 wt. -%, preferably from 0.02 to 1 wt. -% or preferably from 0.04 to 0.5 wt. -%, relative to the total weight of the water insoluble substrate.
12. The kit according to any one of the preceding claims, wherein the polyvalent metal ion chelator comprises an aminocarboxylic acid, a hydroxycarboxylic acid, a hydroxyaminocarboxylic acid, a polyphosphonic acid, another phosphorus-containing organic acid, or a mixture thereof.
13. The kit according to any one of the preceding claims, wherein the at least one water soluble chelating agent is selected from the group consisting of sodium citrate, disodium EDTA, tetrasodium GLDA, trisodium EDDS, sodium phytate, potassium phytate, and mixtures thereof.
14. The kit according to any one of the preceding claims, wherein the at least one water-soluble multivalent metal ion chelator is present in the second composition in an amount of from 0.1 wt% to 1 wt%, preferably from 0.2 wt% to 0.4 wt%, relative to the total weight of the second composition.
15. The kit according to any one of the preceding claims, wherein the at least one gelling agent comprises gelatin, pectin, gellan gum, carrageenan, agar, alkali metal salts of alginic acid and mixtures thereof.
16. Kit according to any one of the preceding claims, wherein the gelling agent is selected from alkali metal alginic acid compounds.
17. The kit according to claim 16, wherein the alkali metal alginic acid compound is selected from alkali metal alginates, alkali metal salts of alginic acid derivatives or mixtures thereof, preferably selected from sodium alginate, potassium alginate, lithium alginate, sodium polyethylene glycol alginate, potassium polyethylene glycol alginate, lithium polyethylene glycol alginate or mixtures thereof.
18. The kit according to claim 16, wherein the alkali metal alginic acid compound is selected from the group consisting of sodium alginate and potassium alginate, more preferably sodium alginate.
19. Kit according to any one of the preceding claims, wherein the at least one water-soluble gelling agent is present in the second composition at from 0.1% to 0.5% by weight, preferably from 0.1% to 0.3% by weight, relative to the total weight of the second composition.
20. Kit according to any one of the preceding claims, wherein the at least one aqueous phase is present in the second composition in a range from 10% to 99% by weight, preferably from 50% to 99% by weight, relative to the total weight of the second composition.
21. Kit according to any one of the preceding claims, wherein the weight ratio of the first composition to the second composition is from 1:3 to 1:20, preferably from 1:8 to 1: 15.
22. Kit according to any one of the preceding claims, wherein the second composition comprises at least one hydrophilic gelling agent and/or at least one active agent.
23. The kit according to any one of the preceding claims, wherein the second composition comprises the water-soluble polyhydroxy polymer.
24. Kit according to any of the preceding claims, presented as a mask, comprising:
1) nonwoven fabric made from hydroxyl-rich fibers comprising from 0.01 to 5 wt. -%, preferably from 0.02 to 1 wt. -% or preferably from 0.04 to 0.5% of calcium sulfate or calcium carbonate, and from 0.001 to 1 wt. -%, in particular from 0.01 to 0.1 wt. -%, like from 0.01 to 0.06% of HEC or HPC, relative to the total weight of the nonwoven fabric, and
2) a composition comprising, relative to the total weight of the composition, from 10% to 99% by weight, preferably from 50% to 99% by weight, of at least one aqueous phase, from 0.1% to 0.5% by weight, preferably from 0.1% to 0.3% by weight, of a water-soluble chelating agent and from 0.1% to 0.5% by weight, preferably from 0.2% to 0.4% by weight, of a water-soluble gelling agent,
wherein the weight ratio of the nonwoven fabric to the composition is from 1:3 to 1:20, preferably from 1:8 to 1: 15.
25. Kit according to any one of the preceding claims, wherein the amounts of the chelating agent and the gelling agent are selected such that the molar ratio of the part released by the chelating agent that can be chelated with multivalent cations to the part released by the gelling agent that can form a gel with multivalent cations is from about 10:1 to about 1:1, preferably from about 5:1 to about 2: 1.
26. Use of a kit according to any one of the preceding claims for caring for keratin materials, in particular the skin, for managing skin wounds, for preventing post-operative adhesion formation or for filling or repairing osteochondral defects.
27. Method for caring for keratin materials, in particular the skin, for managing skin wounds, for preventing post-operative adhesion formation or for filling or repairing osteochondral defects, comprising the step of compounding a first and a second composition of a kit according to any one of the preceding claims in a weight ratio of the first to the second composition of from 1:3 to 1:20, preferably from 1:8 to 1:15, then applying to the site where the mixture thus obtained is required.
28. Use of a second composition as claimed in any one of the preceding claims as part of the juice or sap of a mask product, wherein the mask product comprises, separately from the second composition, a fabric or tissue comprising the at least one water-insoluble multivalent metal salt.
29. A mask package 1 comprising:
1) a first composition comprising at least one water-insoluble polyvalent metal salt, at least one hydroxyl-rich fiber, preferably regenerated cellulose or cotton fiber, and at least one water-soluble polyhydroxyl polymer, wherein said at least one water-soluble polyhydroxyl polymer is homogeneously loaded onto said hydroxyl-rich fiber, and
2) a fourth composition comprising at least one aqueous phase, and
b) at least one water-soluble gelling agent capable of forming a gel with the polyvalent metal ion,
wherein the first composition and the fourth composition are placed separately from each other.
30. The mask pack 1 according to claim 29 wherein said water insoluble polyvalent metal salt is calcium alginate, calcium sulfate or calcium carbonate.
31. A mask pack 1 according to claim 29 or 30 wherein said water soluble polyhydroxy polymer comprises polyhydroxy carboxylic acid, acid ester; a polyhydroxycellulose or a mixture thereof, preferably hydroxyethylcellulose, hydroxypropylcellulose, hydroxypropylmethylcellulose, hydroxyethylmethylcellulose, hydroxyethylethylcellulose or hydroxybutylmethylcellulose.
32. A mask pack 1 according to any one of the preceding claims 29 to 31 wherein said at least one hydroxyl rich fibre is selected from the group consisting of viscose, modal, lyocell, cuprammonium, cotton and mixtures thereof.
33. A mask pack 1 according to any one of the preceding claims 29 to 31 wherein said water soluble polyhydroxy polymer is hydroxyethyl cellulose or hydroxypropyl cellulose or mixtures thereof and said at least one hydroxyl rich fiber is selected from the group consisting of viscose, modal, lyocell, cuprammonium, cotton and mixtures thereof.
34. A mask pack 1 according to any one of the preceding claims 29 to 33 wherein said at least one gelling agent comprises gelatin, pectin, gellan gum, carrageenan, agar, alkali metal salts of alginic acid and mixtures thereof, preferably selected from the group consisting of sodium alginate and potassium alginate, more preferably sodium alginate.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210758396.0A CN115192473B (en) | 2018-12-29 | Kit for caring skin |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/CN2018/125363 WO2020133361A1 (en) | 2018-12-29 | 2018-12-29 | Kit for caring for the skin |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210758396.0A Division CN115192473B (en) | 2018-12-29 | Kit for caring skin |
Publications (2)
Publication Number | Publication Date |
---|---|
CN113194908A true CN113194908A (en) | 2021-07-30 |
CN113194908B CN113194908B (en) | 2024-01-16 |
Family
ID=71129544
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201880100560.0A Active CN113194908B (en) | 2018-12-29 | 2018-12-29 | Kit for caring skin |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN113194908B (en) |
WO (1) | WO2020133361A1 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN117279614A (en) * | 2021-03-31 | 2023-12-22 | 莱雅公司 | Composition for caring skin and package for containing the same |
WO2022226872A1 (en) * | 2021-04-29 | 2022-11-03 | L'oreal | Kit for caring for the skin |
CN117858690A (en) * | 2021-08-25 | 2024-04-09 | 莱雅公司 | Mask for caring keratin materials |
WO2023184295A1 (en) * | 2022-03-31 | 2023-10-05 | L'oreal | Composition for caring for keratin material |
WO2023184315A1 (en) * | 2022-03-31 | 2023-10-05 | L'oreal | Kit for caring for keratin materials |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010070234A2 (en) * | 2008-12-19 | 2010-06-24 | L'oreal | Kit for coating keratin substances comprising a polysaccharide and an ionic or dative complexing agent |
CN102940583A (en) * | 2012-11-26 | 2013-02-27 | 中国工程物理研究院核物理与化学研究所 | Thermosensitive hydrogel capable of being used as nutrition mask and preparation method of thermosensitive hydrogel |
JP2016222612A (en) * | 2015-06-01 | 2016-12-28 | 昭和電工株式会社 | Cosmetic and skin external preparation |
JP2017052706A (en) * | 2015-09-07 | 2017-03-16 | 一丸ファルコス株式会社 | Cosmetic composition containing granules |
US20170290747A1 (en) * | 2014-08-28 | 2017-10-12 | L'oreal | Gel-type cosmetic composition with improved staying power |
TR201619953A2 (en) * | 2016-12-28 | 2018-07-23 | Buelent Karaagac | TOPICAL THERAPEUTIC FORMULATIONS |
-
2018
- 2018-12-29 WO PCT/CN2018/125363 patent/WO2020133361A1/en active Application Filing
- 2018-12-29 CN CN201880100560.0A patent/CN113194908B/en active Active
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010070234A2 (en) * | 2008-12-19 | 2010-06-24 | L'oreal | Kit for coating keratin substances comprising a polysaccharide and an ionic or dative complexing agent |
CN102940583A (en) * | 2012-11-26 | 2013-02-27 | 中国工程物理研究院核物理与化学研究所 | Thermosensitive hydrogel capable of being used as nutrition mask and preparation method of thermosensitive hydrogel |
US20170290747A1 (en) * | 2014-08-28 | 2017-10-12 | L'oreal | Gel-type cosmetic composition with improved staying power |
JP2016222612A (en) * | 2015-06-01 | 2016-12-28 | 昭和電工株式会社 | Cosmetic and skin external preparation |
JP2017052706A (en) * | 2015-09-07 | 2017-03-16 | 一丸ファルコス株式会社 | Cosmetic composition containing granules |
TR201619953A2 (en) * | 2016-12-28 | 2018-07-23 | Buelent Karaagac | TOPICAL THERAPEUTIC FORMULATIONS |
Also Published As
Publication number | Publication date |
---|---|
CN115192473A (en) | 2022-10-18 |
CN113194908B (en) | 2024-01-16 |
WO2020133361A1 (en) | 2020-07-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN112334124A (en) | Kit for caring for skin | |
CN113194908B (en) | Kit for caring skin | |
WO2019047954A1 (en) | Kit for caring for the skin | |
CN113194906B (en) | Kit for skin care | |
CN113226248A (en) | Set for caring skin | |
US11304881B2 (en) | Composition based on an aqueous phase containing a dispersion of an anhydrous composite material | |
US20200138680A1 (en) | Gel-type cosmetic composition | |
Kanlayavattanakul et al. | Biopolysaccharides for skin hydrating cosmetics | |
CN113194921A (en) | Set for caring skin | |
CN113498336A (en) | Kit for skin care | |
WO2019185915A1 (en) | Foaming aqueous gel comprising a modified starch and a non-starchy polysaccharide | |
Gruber | Polysaccharide-based polymers in cosmetics | |
CN115192473B (en) | Kit for caring skin | |
JP7118634B2 (en) | A composition in the form of an O/W emulsion comprising a cereal fermentation product and hectorite | |
CN114340591A (en) | Skin care kit | |
CN115666492A (en) | Skin care kit | |
EP2945599B1 (en) | Cosmetic composition comprising a specific polysaccharide, an anionic fixing polymer and a liquid monoalcohol or polyol, and cosmetic treatment method employing it | |
CN114585348A (en) | Composition for caring skin | |
WO2022123016A1 (en) | Cosmetic substrate of natural origin | |
WO2019185913A1 (en) | Anhydrous exfoliating composition comprising c3-c10 polyols and polysaccharides | |
WO2021245081A1 (en) | Composition comprising at least three types of polysaccharides, at least one pasty compound of plant origin and water | |
CN115768397A (en) | Gelling compositions comprising short chain fatty acid salts | |
WO2023184295A1 (en) | Composition for caring for keratin material | |
CN117813078A (en) | Composition for caring skin | |
FR3023476A1 (en) | AQUEOUS SOLID COMPOSITION CONTAINING A FATTY ACID SALT, A POLYOL AND A HYDROPHILIC GELIFIER |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB03 | Change of inventor or designer information | ||
CB03 | Change of inventor or designer information |
Inventor after: Xu Lingwei Inventor after: Jade Flower Inventor after: Yu Kun Inventor after: Yan Zhipeng Inventor before: Xu Lingwei Inventor before: Ye Yuhua |
|
GR01 | Patent grant | ||
GR01 | Patent grant |